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"The global HIV/AIDS epidemic is an unprecedented crisis that requires an unprecedented response. 
In particular it requires solidarity-- between the healthy and the sick, between rich and poor, and above 
all, between richer and poorer nations. We have 30 million orphans already. How many more do we 
have to get, to wake up?" 
Kofi Annan, Former United Nations Secretary General 
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ABSTRACT 
 
The aim of the study was to explore the practice of antiretroviral (ARV) therapy services, specifically 
regarding the patients’ issues and experiences, as well as the experiences of the health care providers 
rendering these services. Qualitative research methods were used, including a metasynthesis of 
qualitative research articles on human immunodeficiency virus (HIV) positive patients on ARV therapy, 
and phenomenological methods of inquiry.  
 
The study objectives were to conduct a metasynthesis of qualitative research on HIV-positive people 
on ARV therapy; to investigate the experiences of HIV-positive people who are on ARV therapy; to 
identify the constraints faced by HIV-positive people receiving ARV therapy; and to explore adherence 
to ARV therapy.  
 
The study was conducted in eThekwini district in KwaZulu Natal (KZN) province. The district was 
chosen considering the number of clinics rolling out ARV therapy. 
 
Three institutions initiating ARV therapy participated in the study; one urban, one semi-urban and one 
rural clinic, to ensure representation of each type. Participants were recruited from two initiating 
hospitals and one Community Health Centre providing ARV therapy. 
 
The metasynthesis revealed a shared set of four themes viz.: 
 
1. Acceptance of, and coping with, HIV positive status  
2. Social support and disclosure 
3. Experiences and beliefs about HIV medication and health care  
4. Provider relationships and health system factors 
 
Qualitative analyses of interviews with clients indicated their experiences and concerns, and were 
summarized in these themes:  
 
1. Life before and after knowing HIV status 
2. Initiating and continuing ARV therapy 
3. Adherence to, and side effects of,  the ARV therapy treatment 
4. Social support for people on ARV treatment 
vi 
 
 
5. Positive outcomes of being on ARV treatment  
6. Improving access to ARV treatment services 
 
Analyses of in-depth interviews with health care providers specified their experiences, and were 
categorized into three themes viz.: 
 
1. Establishing and maintaining a good client-provider relationship 
2. Facilitators of and adherence to ARV treatment 
3. Barriers to access to treatment 
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CHAPTER 1   
1. INTRODUCTION AND RATIONALE FOR THE STUDY 
 
1.1 BACKGROUND TO THE STUDY 
The AIDS epidemic continues to expand globally: in 2005, an estimated 38.6 million people 
worldwide were living with HIV (Joint United Nations Programme on HIV and AIDS [UNAIDS], 
2006:8); an estimated 4.1 million people became newly infected with HIV; and 2.8 million lost 
their lives to AIDS (UNAIDS, 2006: 8). 
 
South Africa’s AIDS epidemic, one of the worst in the world, shows no evidence of decline. 
Based on an extensive antenatal clinic surveillance system, as well as national surveys with 
HIV-testing and mortality-data from its civil registration system, an estimated 5.5 million people 
were living with HIV in 2005, and an estimated 18.8% of adults (aged 15-49 years) were living 
with HIV in 2005 (UNAIDS, 2006:17). 
 
Almost one in three pregnant women attending public antenatal clinics were living with HIV in 
2004, and trends over time show a steady increase in HIV prevalence (UNAIDS, 2006:11).  
 
While the KwaZulu-Natal province has the highest HIV preponderance in South Africa, the 
national antenatal HIV prevalence has steadily increased from 32.5% in 1999 to a peak of 
40.7% in 2004. A similar HIV prevalence trend is shown in KZN, where the clinics serving 
urban communities showed a constant prevalence rate from 2006 to 2007. The districts that 
had a prevalence of more than 40% in 2006 have remained constant, or have shown a 
decrease, in 2007. A slight decline from 40.7% to 39, 8% was noticed in 2007 which was a 
1.1% decline (National Department of Health South Africa, 2008:16).  
 
The citizens of South Africa had reason to hope for a good quality of life for people living with 
HIV and AIDS (PLWHA) when the Operational Plan for Comprehensive HIV and AIDS Care, 
Management and Treatment for South Africa (2003) came into existence. The pillars of this 
are: prevention, treatment, care and support. In 2004, in meeting the objectives of the plan, the 
South African government rolled out the ARV programme to provide free therapy to South 
Africans whose cluster of differentiation 4, a glycoprotein that is found primarily on the surface 
of helper T cells (CD4), count was below 200cells/mm3. However, the latest clinical guidelines 
for the management of HIV and AIDS in adults and adolescents, approved in 2010, stated that 
patients co-infected with HIV and tuberculosis (TB); pregnant women; and patients with multi-
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drug resistant and extreme drug resistant TB can be initiated on ARV therapy when their CD4 
count falls below 350 cells/mm3 (NDoH 2010:8).  
 
The plan was implemented in the first quarter of 2004 in South Africa, and, although ARV 
treatment is not a cure for AIDS and does not eradicate the virus, ARV therapy does slow 
down HIV replication, allowing for the regeneration of the immune system.  However, the 
medication does need to be taken every day for the rest of the person’s life for maximum 
suppression of the virus, and non-adherence can lead to the development of resistance in the 
virus to treatment. Ensuring compliance and reducing the number of defaulters is of critical 
importance in combating HIV and AIDS. 
 
In KZN 17, 264 patients were assessed and 1, 556 were on treatment by September 2004 
(NDoH, 2004:1). Stewart, Padarath and Bamford (2004:3) state that the provision of ARV 
therapy has been credited with having a significantly positive effect on the lives of PLWHA. 
Where it was widely provided, it had been responsible for emptying wards for PLWHAs in the 
hospitals, for dramatic falls in AIDS related mortality and morbidity and for people returning to 
their homes, families and jobs. However, provision of ARV treatment in developing countries 
had been limited due to a number of factors, most importantly the high costs of ARVs and 
inadequate infrastructure.  It is of importance to note that, although ARVs are provided free to 
South African citizens with CD4 counts less than 200 cells/mm3 or to those with clinical AIDS, 
the service is costly to clients because of repeated visits, transport costs to and from the ARV 
sites, and the long waiting times for access to treatment -it is also a prerequisite that clients 
attend three ARV literacy sessions before being initiated on therapy. 
  
The chronic shortage of health care providers is recognized as one of the major bottlenecks to 
health care provision, including the scaling up of ARV therapy. The impact is most devastating 
in rural areas where the human resource crisis is most acute.  
 
The issue of stigma, and the subsequent fear of disclosure of HIV status, have also been 
hindering factors in the accessing of ARV therapy by the people that need it -people preferred 
not to be seen utilizing the ARV services, as utilization confirmed one’s HIV status. The 
process of accreditation of health care facilities began in South Africa with the introduction of 
ARV therapy, and this entailed assessment of facilities for both the availability of resources and 
the sustainability to provide ARV therapy services. The assessment criteria of potential sites 
included infrastructure, personnel and data capability.  
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1.2  MOTIVATION FOR THE STUDY 
I conducted ARV training for professional nurses in the KZN province, and also provided 
support to sites initiating ARV treatment in the eThekwini district from 2004 to 2006, and this 
piqued my interest in the subject, and helped make my decision to embark on this research 
study. As a result of transferring knowledge and skills to professional nurses on the 
comprehensive management of HIV and AIDS, I developed an interest in working closely with 
PLWHA, taking ARV treatment as their chronic medication. I also developed a desire to 
engage in discussions with the health care providers providing services on the comprehensive 
management of HIV and AIDS, so as to help identify gaps in service delivery. 
 
1.3  SIGNIFICANCE FOR THE STUDY 
This research study documented the experiences of individuals who were already receiving 
ARV treatment, as well as the experiences of providers rendering the ARV therapy services.  
The findings of the study could be shared with the senior management team in the eThekwini 
health district office. They could also be incorporated into training workshops, and be shared 
with professional nurses who work in ARV sites. 
 
1.4  PROBLEM STATEMENT 
Clients on the ARV programme are faced with many challenges, some of which are:  
 The stigma attached to entering the ARV therapy programme 
 Poor access to treatment 
 Poor- or non-adherence to treatment 
 Lack of psychosocial support  
 Prevention of re-infection 
 
These challenges may lead to a poor uptake of therapy, development of resistance to 
treatment for those already in the programme, stress and feelings of inadequacy, and spread 
of the virus due to irresponsible behaviour perpetuated by unsafe practices. Health care 
providers are also faced with several challenges in implementing a comprehensive package of 
prevention, treatment, care and support to PLWHA. These challenges are common to the 
prevention of mother to child transmission (PMTCT) of HIV and ARV treatment programmes in 
developing countries. Other non-HIV health services experience similar challenges. These 
challenges include: 
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 lack of human resources  
 staff stress and burnout 
 negative attitudes towards clients 
 lack of privacy 
 lack of material resources 
 
The provision of ARV therapy has been limited by the poorly developed health care 
infrastructure of many developing countries.  According to Malta, Peterson, Clair, Freitas and 
Bastos (2005:1424), access to treatment, care and support for PLWHA remains grossly 
inadequate. Insufficient capacity in the South African health sector, including infrastructure 
limitations and shortage of trained personnel, are major obstacles to ARV treatment delivery in 
many countries.  These obstructions operate at a variety of levels and these obstacles can be 
summarized as follows:  
 
 Financial: the cost of providing ARV therapy, particularly the costs of ARV drugs  
 Organisational: weak health care infrastructure/systems to deliver ARV therapy 
 Physical: this problem includes the lack of transport and transport infrastructure for HIV-
positive people (to get to sources of testing, drugs and monitoring) 
 Social: such as treatment providers’ discriminating against people with HIV by refusing 
treatment or offering sub-standard treatment, and the fear of stigma attached to the 
disease   (Stewart et al, 2004:8) 
 
These are examples of the multitude of challenges presented by the adequate provision of 
ARV therapy services in South Africa, including the eThekwini district in KZN, where the study 
was conducted.  
 
The issue of stigma, and the subsequent fear of disclosure of HIV status, have also been 
hindering factors to accessing ARV treatment; and, since one of the main problems facing 
clients on ARV therapy is access to facilities, adherence and stigma related. Bottlenecks in 
service delivery, including long waiting times and an uncompassionate staff attitude, contribute 
to the inaccessibility of the service. Lack of knowledge, poor and/or lack of client-provider 
communication and the aforementioned stigma attached to the ARV therapy service may affect 
the client’s adherence to treatment regimen. 
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The problem is that adherence of patients to ARV therapy is compromised due to the 
inaccessibility of the service, as well as the stigma attached to PLWHA, and thus to the entire 
ARV therapy programme. In the face of these obstacles, the best system in helping PLWHA in 
South Africa to adhere to ARV therapy is still unknown.  
 
1.5  PURPOSE STATEMENT 
The purpose of the study was twofold: 
1. It aimed to explore the practice of the ARV therapy rollout, based on the patients’ 
experiences as well as the experiences of the health care workers rendering the services 
(in the selected ARV initiating clinics in the eThekwini district of KwaZulu-Natal) 
2.  It aimed to use both the patients and the providers' opinions to compile a support guideline 
for ARV services for the clinics in the eThekwini district. 
 
1.6  RESEARCH QUESTIONS 
1. What are the problems and experiences of patients and health care providers in relation to 
accessing ARV therapy?  
2. What are the best practices for rendering ARV therapy in the eThekwini district of KwaZulu- 
Natal? 
 
1.7  OBJECTIVES OF THE STUDY 
The study objectives were to: 
 Conduct a metasynthesis of qualitative research on HIV-positive people on ARV therapy: 
their feelings, concerns, needs and problems regarding ARV therapy 
 Investigate the experiences of HIV-positive people who are on ARV therapy. 
 Identify the constraints faced by HIV-positive people receiving ARV treatment 
 Explore adherence to ARV treatment  
 Explore the experiences of health care providers who have been working on the ARV 
therapy programme since its inception in 2004 
 Compile a support guideline for ARV therapy services in eThekwini district 
 
1.8  THEORETICAL ASSUMPTIONS 
According to Polit and Beck (2008:14), an assumption is “a basic principle that is believed to 
be true without requiring proof or verification”. Such assumptions form part of the discipline of 
nursing. Unlike meta-theoretical assumptions, theoretical assumptions lend themselves to 
empirical testing. In order to be of use in the research field, theoretical assumptions are 
expressed as statements, which in turn help to shape the conceptual framework of the study. 
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1.8.1  Theoretical Statements 
Departing from modernist thought, no single theoretical approach was delineated for this study, 
and, consequently, no conceptual framework was developed.  
The research field was approached with openness to different views and understandings of 
reality, and the belief that this reality is a rational construction of experiences and interactions. 
A multiplicity of viewpoints was anticipated, which required the researcher to engage in a 
reflexive analysis of the many different truths and layers of understanding she was presented 
with. Postmodernist thought has shaped these pronouncements and so the approach to this 
study is characterized by elements of postmodernism. 
 
Postmodern thinking emphasizes the value of deconstruction; that is, taking apart old ideas 
and structures and reconstruction and putting them back together in new ways (Polit & Beck, 
2008:15). 
 
1.8.2  Definition of Terms 
In the absence of a conceptual framework as a point of departure, terms used in this study 
were theoretically defined below. These terms will be used throughout the study. 
 
1.8.2.1 Operational definitions 
 ARVs, ARV therapy (ART), Highly Active ARV Therapy (HAART) 
These are drugs that suppress the replication of HIV. They do not cure the disease but turn 
HIV and AIDS from being a fatal condition to a chronic one, manageable with medication. 
These drugs improve the quality of life of PLWHA, as they prevent the onset of 
opportunistic infections. The terms ARVs, ART and HAART are used interchangeably. The 
term ARVs will be used for purposes of this study.  
 
 Clients 
These are PWHA, consumers of ARV therapy/people using ARVs as their chronic 
medication. 
 
 Experience 
According to the Pocket Oxford dictionary (2005), “experience” means “knowledge based 
on personal observation or contact or incident that affects one”. In this research study, 
“experience” shall mean “the difficulties and challenges faced by clients throughout their 
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journey from the time they tested HIV positive throughout their daily encounters while 
taking lifelong ARV therapy”.  
 Health care providers 
For the purposes of this research, a health care provider shall be any staff member who 
provides ARV therapy services to the clients, but at least one professional nurse in charge 
of the ARV clinic will be interviewed. 
 
 Adherence 
According to The Pocket Oxford Dictionary (2005), to “adhere” means “to stick fast to 
substance, person, party, and opinion”. For this research purposes, “adherence” shall 
mean “taking ARVs everyday/not missing ARV doses”. 
 
 Constraints 
This shall mean “the difficulties faced by HIV positive clients receiving ARV therapy”. 
 
 Metasynthesis 
“Metasynthesis” is used here as an umbrella term referring to the synthesis of findings 
across multiple qualitative reports to create a new interpretation. Types of metasynthesis 
include: 
 theory building 
 meta-study 
 grounded formal theory 
  theory explication  
 descriptive study 
 
 In this research a meta-study was done. 
 
1.9  DESCRIPTION OF THE STUDY SITE 
The study was conducted in the eThekwini district in the KZN province of South Africa. Prior to 
1994, the territory now known as KZN was made up of the province of Natal, and all pieces of 
territory that made up the homeland of KwaZulu. 
 
 History 
From 1839 until 1843 the northern and southern parts of the Zulu Kingdom were briefly a 
Boer republic called Natalia. In 1843 the latter became the British Colony of Natal, although 
Zululand (KwaZulu in Zulu) remained independent until 1879.  
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It is called the garden province and is the home of the Zulu nation. Located in the southeast 
of the country, it borders three other provinces and the countries of Mozambique, 
Swaziland, and Lesotho, along with a long shoreline on the Indian Ocean. 
 
 Climate 
KZN has a varied climate. Generally, the coast is subtropical with inland regions becoming 
progressively colder. Durban on the south coast has an annual rainfall of 1009 mm, with 
the daytime temperature peaking from January to March at 28 °C (82 °F), with a minimum 
of 21 °C (70 °F), and then dropping to daytime highs of 23 °C (73 °F) with a minimum of 
11 °C (52 °F) from June to August. 
 
 Provincial Districts 
KZN is divided into eleven districts. One of these, eThekwini, is a metropolitan municipality 
and the others are district municipalities. 
 
 Political Landscape 
KZN, as the name may suggest, is also the home to the Zulu monarch, King Goodwill 
Zwelithini kaBhekuzulu. Although not holding any direct political power, the Zulu king is 
provided a stipend by the National Government, and holds considerable sway over more 
traditionalist Zulu people in the province. 
 
 HIV Prevalence 
One of the most urgent crises facing the KZN province is the unparalleled prevalence of the 
HIV virus among its citizens. South Africa as a whole has more HIV-positive citizens than 
any other nation, and, among South Africa's nine provinces, KZN has the highest rate of 
HIV infection, 39 percent, (UNAIDS 2009). 
  
Without the proper nutrition, health care or medicine that is available in more developed 
countries, large numbers of people suffer and die from AIDS-related complications. In 
some heavily infected areas, the epidemic has left behind many orphans cared for by 
elderly grandparents. HIV and AIDS also severely retard economic growth by destroying 
human capital.  
 
  
9 
 
 
 eThekwini  District 
District Health services are jointly provided by the Provincial DoH and the Local 
Government authority, with the former contributing 60% and the latter 40%. The eThekwini 
District office also manages the Ilembe District. The Provincial Primary Health Care (PHC) 
service in the Metro has a number of services/programmes which need to be integrated 
within the context of the overall city plan, as well as the process of devolving PHC Services 
to Local Government. The eThekwini health District is further subdivided into three sub-
districts namely the South, North and West.  
 
The District has a total number of 140 health facilities, that is, fifteen hospitals, 7 
Community Health Centres (CHCs), 113 PHCs, 4 TB hospitals and 1 prison (within which 
there is a health facility). There are twenty ARV therapy service points in the District: 8 in 
the South, 7 in the North and 5 in Western sub-districts. The map below highlights the 
clearly marked health districts of KZN. 
 
 
Figure 1.1: KwaZulu-Natal Health Districts 
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1.10  DESCRIPTION OF STUDY PARTICIPANTS 
The participants of the study were selected from the three health facilities accredited as 
initiating-sites for providing ARV therapy. Participants were the clients registered in the ARV 
programme and the health care providers delivering ARV services in the selected institutions. 
The clients had a poor socio-economic background, ranging from being unemployed to 
domestic and/ or factory workers. Their level of education also ranged from primary to 
secondary level of education. Only one client had a matriculation certificate and had registered 
at a University for tertiary education. All clients but one were females, since women and girls 
continue to be affected disproportionately by HIV in sub-Saharan Africa. Women’s vulnerability 
to HIV stems not only from their greater physiological susceptibility to heterosexual 
transmission, but also to the severe social, legal and economic disadvantages they often 
confront (UNAIDS, 2009:22). The women’ risk to HIV infection had also been exacerbated by 
poverty; examples of this including girls practicing transactional sex as well as other cases of 
multiple partners.  
 
1.11  LAYOUT OF THE THESIS 
The study comprised of the following chapters: 
 
 Chapter One: Introduction and Rationale For The Study 
This chapter described the background to the study. The significance of this research study 
was described. The purpose statement and specific objectives were outlined. The terms 
that were used throughout the study were defined. 
 
 Chapter Two: Literature Review 
This chapter presented a discussion of findings from the literature related to HIV and AIDS; 
adherence to ARV therapy; and the needs, problems and challenges faced by HIV positive 
clients. 
 
 Chapter Three: Research Methodology 
The research methodology for the exploration of the experiences of clients on ARV therapy 
and their health care providers was discussed in this chapter. The target population and the 
multiple phases of research were explained. Each phase was explained in detail including 
the design, data collection methods, data analysis and ethical considerations. 
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 Chapter Four: Results and Description of Findings 
The results were described according to the different phases of the study. The results from 
the phenomenological enquiries which formed part of all the phases were discussed. This 
chapter also described the findings from the metasynthesis of qualitative research studies 
conducted in the field of HIV and AIDS. 
 
 Chapter Five: Conclusions, Limitations and Recommendations for the Study 
In this chapter the findings, conclusions, limitations and recommendations of the study 
were described. 
 
1.12  CONCLUSION 
In chapter one, the background and significance of the study were outlined. This chapter 
further highlighted the problem statement and purpose statement; the terms used throughout 
the study were defined; and the thesis layout was presented. The next chapter will present a 
discussion of findings from literature related to HIV and AIDS and ARV therapy.   
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CHAPTER 2 
2. LITERATURE REVIEW 
 
2.1  INTRODUCTION 
Access to good quality ARV treatment has transformed the prognosis for PLWHA in the 
developed world. Although it is also feasible, and desirable, to deliver ARV drugs in resource-
poor settings, very few of the 95% of PLWHA, who live in developing  countries receive them 
(Furber, Hodgson, Desclaux & Mukasa, 2004:1281). The rapid scaling-up of ARV therapy in 
sub-Saharan Africa is generating considerable public health gains. As of December 2008, 44% 
of adults and children in need of ARV therapy in the region were estimated to be receiving 
these services, as compared to five years earlier when the estimated regional treatment 
coverage was only 2% (UNAIDS, 2009:25). Although treatment scale-up is having a profound 
effect on HIV related morbidity and mortality in the country, important access gaps remain. 
 
By the end of June 2009, South Africa was providing free ARV therapy to an estimated 40% of 
adults and 10% of children with advanced HIV infection. The number of HIV infected persons 
enrolled onto the national ART programme has increased over the last few years to over 940 
000 at the end of November 2009 (The National HIV Counselling and Testing Campaign 
Strategy, 2010:5) 
 
Furthermore, Furber et al. (2004:1281) state that, ideally, care for PLWHA should start with 
voluntary counselling and testing (VCT). However, only 10% of the people who need testing in 
low- and middle-income countries have access to these services, and therefore most are 
unaware of their serological status. Care for PLWHA should include psychological, social, and 
economic support as well as broad based medical care which incorporates nutritional advice, 
prevention and treatment of opportunistic infections, and palliative care. The issue of 
confidentiality is a crucially important one in view of widespread AIDS related stigma and 
discrimination. AIDS related stigma is “the process of devaluation of people living with or 
associated with HIV and AIDS”. Despite more than twenty years of AIDS education and 
awareness, the stigmatisation of PLWHA remains strong, although it is now being manifested 
in more sophisticated ways (Furber et al, 2004:1281).  
 
Even when a person meets the criteria for initiating treatment, non-disclosure of one’s HIV 
status due to fear of stigmatisation contributes to a lack of access to the necessary ARV 
treatment.  
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Holzemer et al, (2008:319-320) explored the reasons for disclosing and non- disclosing of HIV 
status. Reasons for disclosing included: 
 breaking the silence 
 economic factors, especially poverty, which led PLWHA to disclose to a health care worker 
 support in the form of prayer  
 the appearance of physical symptoms, which gave people no choice but to inform their 
relatives about their HIV status 
 
Reasons for not disclosing included: 
 anxiety 
 denial, and the subsequent comfort found in keeping the illness a secret  
 concerns about confidentiality  
 seeing how other PLWHA were treated 
 not being able to predict the community’s reaction 
  
Failure to disclose one’s status delays initiation of care; treatment; and support, all of which 
PLWHA need as the disease progresses; this contributes to late (or no) initiation of ARV 
treatment when opportunistic infections have already begun to set in.  
 
Holzemer et al, (2008:320) also state some things that promote disclosure; these include 
 counselling 
 information 
 education 
 advice 
 
2.2  ADHERENCE TO ARV THERAPY 
Adherence to ARV therapy is essential to maintaining long-term health benefits, and avoiding 
the development of viral resistance. It is not possible for health care providers to reliably 
predict which individuals will ultimately be adherent to their treatment plan, since this is 
because adherence does not correlate with gender, cultural background, socio-economic or 
educational level; nor does it correlate with language barriers between provider and patient  
(South African National ARV Treatment Guidelines, 2004:52). 
 
The results of the study conducted by Weiser, Wolfe, Bangsberg, Thior, Gilbert, Makhema, 
Kebaabetswe, Dickenson, Mompati, Essex and Marlink (2003:281) in Botswana, state that the 
lack of strict adherence to HAART is considered one of the key challenges to AIDS care 
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worldwide. Estimates of average rates of non-adherence with ARV therapy range from 50% to 
70% in a wide variety of social and cultural settings, and the risks associated with non-
adherence are extensive at both individual and societal levels.  
 
The study by Weiser et al (2003:281) confirms that treatment adherence has been closely 
correlated with viral suppression, while non-adherence has contributed to progression to AIDS, 
the development of multidrug resistance, and even death. Non-adherence to treatment is the 
major threat to the ARV therapy programme in sub-Saharan Africa. A recent study conducted 
by Peltzer, Friend-du Preez, Ramlagan and Anderson (2010:1) in KwaZulu Natal, South Africa 
found that a good proportion of patients were adherent to treatment using different adherence 
instruments. The important socio-economic predictors of ART adherence include residing in 
the urban area and adequate physical environment including transport and access to health 
services. Living in an urban area is likely to be associated with lower transport costs and fewer 
disruptions in access to medications. (Peltzer et al (2010:6). It is true that poor access due to 
long distances to health services and unaffordable transport costs have negative effects on 
adherence to ART. This has been seen especially in patients coming from rural areas failing to 
keep regular appointments for their chronic care and medications. 
 
The ARV treatment programme is a complex programme, as it requires lifetime commitment by 
the patient. The chronic nature of the virus necessitates that patients take the medication for 
life, and thus patient adherence to life-long drug therapies is essential for the success of the 
ARV therapy programme. Patients on ARVs need to have access to sufficient drugs of correct 
potency, appropriate health care, knowledgeable providers and the relevant education.  
 
El-Khatib and Richter (2009:412) report that the Free State province has the third highest HIV-
prevalence (31%) in the country since December 2008. The Free State provincial DoH stopped 
initiating ARVs because of drugs that were out of stock and lack of funding. This situation 
contributes to high morbidity and mortality, and the lack of trust in the health system. This also 
impacts negatively on adherence of existing patients on the ARV programme, and can lead to 
life threatening effects with emerging drug resistant strains of HIV.  
 
Authors further report that patients already on ARVs share their medication with neighbours, 
relatives or friends who experience delays in receiving ARVs. This practice raises serious 
public health concerns about drug failure, subsequent and more expensive drug regimens, and 
the spread of drug- resistant strains of HIV (El-Khatib et al, 2009:412). 
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2.3  BARRIERS TO ARV THERAPY 
The main barrier to the initiation of and compliance to ARV therapy is the stigma associated 
with HIV and AIDS. The stigma also discourages people from seeking VCT services. A study 
on barriers to ARV adherence for PLWHA conducted in Botswana using both qualitative and 
quantitative methodologies indicates that patients stated their health providers as having 
significantly impacted upon their lives in the medical, social and psychological realms. This 
study states that physicians and nurses were often cited by patients as their primary source of 
support in coping with the challenges of living with their illness (Weiser et al, 2003:284). This is 
in contrast with another qualitative study done in Brazil by Malta, Peterson, Clair et al 
(2005:1424), where in-depth interviews were conducted with 40 physicians treating PLWHA. 
Amongst other questions the interview, topics of the study included experiences in the 
treatment of PLWHA, relationship and dialogue with patients, barriers and facilitators to 
adherence and effectiveness of available services. Barriers to ARV adherence were mainly 
related to the low quality of patient-provider relationship. Other barriers were related to 
patients’ chaotic lifestyles, and inadequate knowledge and the subsequent negative beliefs 
about HIV, AIDS and ARV effectiveness.  
 
PLWHA face not only medical problems but also social problems associated with the disease. 
One of the barriers to reaching those infected with HIV is stigma, which enhances secrecy and 
denial.  According to Mbonu; Borne and De Vries (2009:5), many Sub Saharan Africans are 
reluctant to disclose their HIV status even when they’ve already gone for VCT; moreover, 
those who disclose it are selective about whom they disclose it to. 
 
Barriers to disclosure include 
 fear of stigmatization and the resultant possible victimization 
 distrustfulness of assurances of confidentiality 
 accusations (like that of infidelity) 
 the possibility of abandonment  
 
The consequences of HIV and AIDS stigma may include a low uptake of maternity health 
services by women, a fear of health care workers getting infected and the subsequent less 
adequate provision these of health care workers’ services (Mbonu et al, 2009:11).  
 
Stigma has serious implications for prevention: people do not want to go for VCT, and even 
those who do go for testing do not always disclose their HIV positive status to their sexual 
partners owing to the stigma. Stigma has ongoing effects on adherence to ARV treatment by 
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PLWHA, affecting their quality of life and increasing complications. People do not take 
treatment freely in public, they feel they have to hide when taking treatment in public places, 
and this affects adherence by affecting the times the treatment is taken. 
 
In South Africa, access to ARV therapy is still minimal despite the provision of drugs free of 
charge. The capacity of the health system to implement the ARV therapy programme is the 
main barrier to access; however the drugs are becoming increasingly affordable, especially in 
South Africa where the government provides ARV treatment free of charge to all South 
Africans.  The procurement process and the need to train health care providers is delaying the 
2004 goal of at least one ARV service point per health district as outlined by Ijumba and Poole 
( 2005:319). The key challenges in scaling up ARV therapy programme in the public sector as 
stated by Ijumba and Poole include:  
 the continuing lack of human resources (nurses, doctors, pharmacists, nutritionists, 
dieticians and counsellors)  
 
While not all of these positions need to be filled on a full time basis at the most accessible level 
of care, it is crucial that the primary health care facility must have knowledgeable personnel 
with adequate training on ARVs to be able to operate and manage the programme. 
 
 Lack of adequate infrastructure (including water, sanitation, electricity, communication and 
consulting rooms) and weak support systems (laboratory services, transport and medicine 
supply) 
 The lack of essential services (accessible VCT and effective PMTCT programmes, 
particularly in resource constrained areas  
 The lack of capacity to monitor and evaluate the ARV therapy programme at all levels of 
delivery, starting at the facility level 
 Lack of a strong monitoring and evaluation system. The ability to track and treat patients, 
regardless of where they present is key to ensuring suitable levels of adherence and 
monitoring of treatment outcomes 
 
It is worthwhile learning from the PMTCT project and avoiding the same mistake: 3 years after 
introducing the Nevirapine-based PMTCT programme, it still could not reach many HIV positive 
pregnant women, particularly in rural areas. (Ijumba et al, 2005:335).  
It is of utmost importance to explore the experiences of patients receiving ARV treatment in the 
public sector, and also learn some lessons from the health care providers in the ARV therapy 
programme.  
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A study to explore the knowledge and practices related to HIV and AIDS by rural South 
Africans by Mabunda (2004:300) was conducted in an HIV outpatient clinic in the Limpopo 
Province. Qualitative research methods were used to conduct research with a grounded theory 
approach. Twenty-eight key and general informants participated in individual interviews in the 
summer of 2001. Key informants were recruited from a support group meeting, and they were 
chosen for their specific knowledge and experience of living with HIV and AIDS. General 
informants were chosen for their knowledge and experience related to caring for PLWHA, and 
for their positions in the community e.g. ministers, nurse administrators and employers. The 
findings from the study were that all participants were members of a support group, and they 
had a basic knowledge about HIV and AIDS. However, participants indicated that they lacked 
basic knowledge of HIV and AIDS until they joined the support group (Mabunda, 2004:300). 
 
Another study by Metcalfe, Langstaff, Evans and Paterson (1998:31-32) was conducted to 
examine the feelings, concerns and needs of HIV infected women in a mid-sized Canadian 
city. In order to understand what it was like to live with HIV, the qualitative research method of 
phenomenology was selected to collect data. Methods of data collection included personal and 
telephonic interviews and letters (Metcalfe et al, 1998:31-32). 
 
Findings of the study included that at initial diagnosis shock was the first reaction felt, which 
was then followed by anger. It was further stated that participants gained support from their 
families; however, the family was not always aware of their relative’s status. Coping became 
more effective as the length of time since diagnosis increased. Participants verbalized the 
need to belong to a support group once diagnosed HIV positive. However, there was minimal 
use of community organizations due to lack of knowledge of locally available resources 
(Metcalfe et al, 1998:32). 
 
The use of qualitative research in the study of personal experiences of PLWHA has been 
documented as effective in dealing with sensitive material such as sexual behaviour and 
substance abuse. There is extensive literature about HIV and AIDS, but limited research on the 
experiences of HIV positive people receiving ARV therapy. 
 
2.3.1 Factors Contributing to HIV and AIDS Related Stigma 
HIV and AIDS is a life-threatening disease and people react to it strongly; further, HIV infection 
is still widely associated with behaviours (such as homosexuality, drug addiction, prostitution 
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and promiscuity) that are considered deviant in many societies, and, as a result, most people 
who become infected with HIV face harsh judgement from the communities they live in. 
 
There is a lot of inaccurate information about how HIV is transmitted and this promotes 
misperceptions of personal risk and irrational behaviour; infection is also generally thought to 
be the result of personal irresponsibility. Religious or moral beliefs lead some people to believe 
that being infected with HIV is the result of some moral fault (such as promiscuity or deviant 
sex), that deserves to be punished. 
 
In health care settings, PLWHA experience stigma and discrimination in the form of being 
denied access to medicines and facilities; receiving non-consensual HIV testing; and 
disclosure of purportedly confidential test results. These negative responses are often fuelled 
by ignorance of HIV transmission routes amongst the health care providers. 
(www.avert.org/aidsstigma.htm:).  
 
Stigma can affect many aspects of the day-to-day lives of PLWHA. Loss of social support, 
persecution; isolation; job loss; as well as problems in accessing health care services have 
been reported in a study conducted by Holzemer, Uys, Makoae, Stewart, Phetlhu, 
Dlamini,Greef, Kohi, Chirwa, Cuca and Naidoo (2007:542). The same authors further describe 
the contextual factors within which the process of stigma is conceived. These are described as:  
 environment  
Environmental factors include cultural, economic, political, legal and policy environment. 
 the health care system  
In health care settings informants reported health care workers as a source of 
stigmatization. 
 agents 
Agents of stigma include the individual who may self-stigmatize, family members, work 
colleagues and community members (Holzemer, et al, 2007:547) 
 
2.4  ARV THERAPY IN ADULTS 
The South African National DoH rolled out the National ARV treatment guidelines in 2004.The 
goals of ARV treatment as specified in the guidelines are twofold: 
1. To decrease HIV- related morbidity and mortality  
2. To decrease the incidence of HIV 
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Not everyone infected with HIV qualifies for ARV treatment; the medical criterion for eligibility 
to commence ARVs is a CD4 count below 200 cells/mm3, or a World Health Organization 
(WHO) Stage IV disease, irrespective of CD4 count. This means that even if a client has a 
CD4 count that is above 200 cells/mm3, if he/she presents an AIDS-defining illness which is 
classified as a Stage IV illness according to the WHO, that client is eligible for ARV treatment 
(although the patient must express both willingness and readiness to adhere to the prescribed 
ARV therapy before he/she can receive it).   
 
Although there are important psycho-social considerations which need to be observed, they 
are not exclusion criteria. These considerations include: 
 demonstrated reliability by the client,  
 absence of active alcohol or substance abuse,  
 absence of active depression,  
 disclosure 
 
It is strongly recommended that a patient must have disclosed her HIV status to at least a 
friend or family member or have joined a support group.  
 the client must have insight into his condition, that is, acceptance of his status and the 
consequences thereof 
 
Anecdotal reports from the public state that communities are not satisfied with the criteria for 
initiating ARV therapy. Complaints that have been raised by members of the public include: 
 the long waiting periods before initiation 
 the level of CD4 count at which ARVs are started (200 cells/mm3) 
 disclosure  
 
It is also true that the health system has bottlenecks which impact on delivery of the ARV 
therapy services. Some of the bottlenecks are:  
 shortage of skilled personnel 
 lack of training of staff on ARV therapy 
 protocols and guidelines that are imposed to operational staff without prior training 
 
In South Africa there are two ARV therapy regimens recommended for use in the public sector. 
These are: 
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1.  Regimen 1 
1.1 a:  Stavudine (d4T), lamivudine (3TC) and efavirenz (EFV) 
1.2  b:  Stavudine, lamivudine and nevirapine (NVP) 
2.  Regimen 2: Zidovudine (AZT), didanosine (ddI), lopinavir/ ritonavir  
(National ARV Treatment Guidelines South Africa, 2004:6) 
 
These guidelines have been further supplemented by the South African Clinical Guidelines for 
the Management of HIV and AIDS in Adults and Adolescents, released by the National DoH in 
2010. The latest guidelines have considered people co-infected with both HIV and TB, and 
HIV-positive pregnant women to be initiated on treatment when their CD4 count is ≤ 350 
cells/mm3. The latest guideline recommends replacing d4T with tenofivir (TDF) for all new 
patients needing ARV treatment. 
 
All HIV-positive clients who meet the criteria for initiation of ARV therapy should be 
commenced on regimen 1a, unless contra-indicated. Women in the childbearing age unable to 
guarantee reliable contraception should be put on a nevirapine-containing regimen. If patients 
experience virological failure despite good adherence, they need to be changed to second line 
therapy, with close monitoring of adherence.   
 
Patients on ARV therapy need to visit the clinic regularly in order to check the side effects of 
medication; to do the safety bloods, like liver function tests; and to ensure that the correct drug 
dosaging is being followed. 
 
The key barriers to care are unaffordable costs; the weak availability of inputs and services; 
and poor acceptability, collectively referred to as the “access framework”. Although the drugs 
are provided free to South Africans, other costs incurred by the clients include those incurred 
by travelling long distances to the health facility; the long waiting times, which can result in 
absenteeism from work; and the unaffordable prices of the nutritious food that is vital to 
keeping healthy.  
 
In low- or middle-income countries, patients often either do not seek care or do so only when 
they have access to funds, thus interrupting the necessary continuity of care. Shortage of 
health service inputs (staff, drugs and equipment) often mean that appropriate care is not even 
available. Complex treatment seeking patterns (healer shopping), where a patient consults a 
variety of providers, can also prevent provision of regular chronic care. If health systems are to 
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be organized to reduce access barriers, the patient’s perspective on the difficulties of 
accessing care and the tendency to “healer shopping” need to be understood.  
As a general rule the fight against any diseases is multi-factorial. HIV and AIDS represent the 
paradigm of disease requiring a wide spectrum of interventions (medical, social, cultural, 
economic) to be finally controlled and defeated. Among these interventions, improving access 
to adequate medical care for those in need is crucial. 
 
On 17 April 2002, the South African cabinet reiterated its commitment to the HIV and AIDS and 
Sexually Transmitted Infections Strategic Plan for South Africa 2000-2005, at the same time 
calling for all South Africans to take responsibility for their lives in respect of HIV and AIDS. 
Cabinet noted progress in the implementation of the Strategic Plan and decided on a number 
of measures to strengthen and reinforce these efforts, including: 
 Noting that ARV treatment can help to improve the conditions and health of PLWHA if 
administered at certain stages in the progression of HIV and AIDS 
 in accordance with international standards, the government’s commitment to continue its 
efforts aimed at dealing with the constraints to systemic access to medicines in the public 
sector, including ARVs 
 The South African government’s commitment to providing a comprehensive package of 
care for HIV and AIDS 
 the steps to provide ART to patients in the public sector 
 
The National ART Guidelines released by the National DoH in 2004 served to assist the clinic 
team in the management of patients on ART as outlined in the Comprehensive Plan for HIV 
and AIDS Care, Management and Treatment. 
 
The approach adopted was that of continuum of care, with a holistic patient focus in an 
integrated health system (Figure 2.1). 
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Figure 2.1:  Continuum of Care Approach 
Source: Adapted from FHI (2007) 
 
A comprehensive service for management of HIV related illnesses needs to build on an 
integrated approach which focuses on providing a continuum of care. The continuum of care 
approach refers to integrated, comprehensive services offered to patients throughout every 
aspect of the Care and Treatment Programme, from diagnosis to treatment. 
 
The continuum should encompass all levels of health care, and include:  
 VCT 
 management of sexually transmitted infections 
 family planning 
 reproductive health care 
 TB services and outreach 
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 PMTCT programmes 
 links to support groups  
 
Community-based home care is also an important component of the continuum: being cared 
for in an environment one is familiar with, surrounded by one’s significant others, and promotes 
speedy recovery. Such care includes physical, psychosocial, palliative and spiritual activities.  
The continuum of care is a set of comprehensively linked palliative care, treatment, support 
and prevention services provided at health facilities (hospital/health centres), community and 
home. Figure 2.1 provides an overview of a continuum of care cycle. 
 
As summarized in Figure 2.1 above, the continuum of care approach acknowledges that VCT, 
and encouraging people to know their HIV status, is an entry point to all services from the 
primary health care level to the tertiary level of care which provides specialized services. The 
continuum also acknowledges the important role played by the clients’ significant others, and 
community based structures (like non-governmental organizations (NGOs), churches, peer 
support groups, youth groups and volunteers) in comprehensive management of patients. The 
importance of a multidisciplinary team approach then becomes important in day-to-day 
management of HIV positive patients, with active referral systems in place.  
 
The continuum of care approach enhances ongoing negotiations between the patient and 
his//her significant others, the community support structures and the members of the health 
team.  Active referral mechanisms are necessary at all levels, from the home or community to 
primary level of care (which is the first-line health contact for the client), which may be a 
primary health care centre or a VCT site. 
 
From this level of care clients may be referred to a district or regional facility and then to a 
tertiary facility with specialized services and finally back to the community based structures. 
Other support services like pharmacists, social workers, psychologists and dieticians, also form 
an integral part of the continuum. Therefore, strong referral systems need to be put in place in 
order to ensure that there is no break in the continuity of care.  
 
The continuum of care framework serves as a pathway followed by clients registered on the 
antiretroviral programme in South Africa. 
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Figure 2.2: The Referral Pathway 
Source.www.kznhealth.gov.za/publications.htm/Clinical Guidelines and 
Protocols (2007) 
 
2.4.1  Problems Facing the ART Programme 
Castelli, Pietra, Diallo, Schumacher and Simpore (2010:28-32) shared their work done in 
Burkina Faso, and they mentioned that the problems that are to be addressed in the fight 
against HIV and AIDS in resource constrained countries are multifaceted and are briefly 
analyzed as follows:  
 
 Cost of care  
“Cost of care” includes direct and indirect costs, such as transportation and the loss of 
working days that may contribute to loss to follow up of PLWHA. 
 
 Qualified human resources 
Most qualified health personnel in resource-limited settings are concentrated in urban 
areas, leaving rural areas (where the need for health care is as urgent) understaffed. 
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Training of health care workers in the comprehensive management of HIV and AIDS in 
resource-limited settings is also often inadequate. 
 
 Infrastructure 
The need for a basic infrastructure to perform at least safety monitoring and CD4 cell count 
is paramount, especially in underprivileged rural areas. 
 
 Socio-cultural factors 
The most important socio-cultural barriers that limit the effectiveness of any HIV control 
programme include gender, poor education and stigma. 
 
 Drug-specific constraints  
These include treatment guidelines, toxicity and drug storage. 
 
 Specific complicating issues 
Including pregnancy and lactation, HIV/ Hepatitis B Virus (HBV) co-infection, and HIV/TB 
co-infection 
 
2.5  CONCLUSION 
Stigma is one of the main challenges facing the ART programme, as it discourages people 
from getting tested for HIV, and, if an HIV positive status is know, starting ART.  It also 
severely compromises adherence to ART.  
 
There is agreement in literature that taking ARVs as life-long medications requires strong 
relationships with health providers and considerable support from significant others. The main 
factors contributing to non-adherence to ART were related to poor patient-provider 
relationships. The literature also highlights key challenges facing the ART programme, 
including the continuing lack of human resources and the inaccessibility of essential services, 
like VCT and PMTCT, particularly in rural areas. 
 
In the next chapter the methodology of the study is described with regard to the exploration of 
the experiences of clients on ART, and that of their health care providers. The research 
methods in the different phases of this study are described, with an emphasis on 
phenomenology and metasynthesis. 
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CHAPTER 3 
3. METHODOLOGY 
 
3.1  INTRODUCTION 
This study explored the practices used in caring for HIV positive clients receiving ART in the 
public sector, as well as those of the health care providers rendering the ART services.  
 
This study was a multi-phased study using the qualitative research paradigm. It consisted 
firstly of a metasynthesis, followed by a phenomenological research approach to describe the 
practices and experiences of participants from their own perspective and as experienced in 
their everyday lives. Participants were asked to share their real life stories about the path from 
getting tested for HIV, through to starting and continuing with ART, and were encouraged to 
share both the positive and negative experiences that they had had. 
  
Health care providers rendering ART services were also asked to share their practices and 
experiences while treating HIV and AIDS patients on ART. The interviews were tape recorded 
and field notes were taken to ensure that the lived experiences were captured.  
 
3.2  RESEARCH METHODOLOGY 
The research was conducted in multiple phases, using qualitative enquiry methods to collect 
data. During phase one a metasynthesis of qualitative research articles on HIV positive people 
was conducted. Phase two of research studied the experiences of clients on ART, the 
constraints they were faced with while receiving therapy and issues around adherence to ART. 
Phase three of the study was to document the experiences of health care workers working on 
the antiretroviral programme  
 
3.2.1  Phase One: Metasynthesis of Qualitative Research Articles on HIV-Positive Patients  
on ART 
 
A metasynthesis was conducted during this phase; that is, an investigation of the results and 
processes of previous research studies (primary research). Qualitative research studies 
conducted in the field of HIV and AIDS were retrieved to conduct a metasynthesis.  
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The analysis procedures of meta-study involve three components: metasynthesis, meta-
method and meta-theory. These components do not necessarily unfold sequentially, and are 
frequently conducted concurrently. Metasynthesis is derived from the results of the analytic 
components (Paterson et al, 2001:10).  
 
3.2.1.1 Method 
Paterson’s model (2001) was chosen to conduct the meta-study. Meta-study is composed of 
four distinct components:  
 
1. The analytic components of meta-data-analysis  
This means “the analysis of processed data, from selected qualitative research studies, to 
create a systematically developed, integrated body of knowledge about a specific 
phenomenon” (Paterson, Thorne, Canam & Jillings, 2001:55).  
Analysis of data was done by comparing each individual report with all other reports that 
have a common focus or that share specific and generic properties; for example, all 
research relating to the experiences of PLWHA receiving ART (their concerns and fears). 
Mostly used data analysis methods were identified. 
 
Meta-data -analysis has been interpreted to mean the comparative analysis of research 
findings of primary research studies conducted by a variety of researchers (Paterson et al, 
2001: 55). Noblit and Hare’s (1988) approach to meta-ethnography was used in the meta-
data-analysis phase of the study. The following steps were followed: 
 
 Each primary research report was read in detail, noting how the phenomenon is 
described. Notes were made about the concepts, key metaphors, categories and 
phrases that best describe the phenomenon. 
 Data from the primary research report was then compared and contrasted with the data 
in other studies, as a whole or in subgroups, noting the similarities and differences 
between the key metaphors for each study. Codes were developed manually. 
 A hypothesis about the nature of the relationships between studies was made, and 
these relationships were depicted in a schematic representation. The primary research 
studies were translated into one another by determining how the key metaphors of 
each study relate to those of other accounts  
 These translations were refined until the phenomenon was described in a way that is 
faithful to the interpretations of the original data. 
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2. The analytic components of meta-method 
This is “the study of the epistemological soundness of the existing research as well as the 
ways the methodological applications may have influenced the findings that are generated, 
and includes examination of methodological presuppositions necessary for carrying out 
research; evaluation of research methods in terms of their weaknesses and limitations; 
and codification of new procedural norms for research in the area” (Paterson et al, 
2001:71). 
 
Meta-method begins with an appraisal of the methodologies of individual primary research 
reports. This included: 
 a review of the research question 
 the role of the researcher 
 the sampling procedures 
 the data collection procedures for their fit with the stated research method and their 
influence on the research findings 
 
3. The analytic components of meta-theory 
Paterson et al, (2001:91) defines meta-theory as “a critical exploration of the theoretical 
frameworks or lenses that have provided direction to research and to researchers, as well 
as theory that has arisen from research in a particular field of study”. This entailed: 
 reading primary research reports thoroughly 
 noting the theoretical perspective used  
 noting the presence of any emergent theory  
 deciding which additional theories may have had significant influence on primary 
research 
 
4. The synthetic component of metasynthesis 
According to Peterson et al (2001:13), “metasynthesis brings back together those ideas 
that have been taken apart or deconstructed in the three analytic meta-study processes. It 
represents the creation of a new interpretation of a phenomenon that accounts for the 
data, method and theory by which the phenomenon has been studied by others”. 
 
The additional research processes within which these components are contextualized are  
 formulation of a research question  
 What are the problems and experiences of patients and health care providers regarding   
ART? 
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 What are the best practices for rendering ART in KwaZulu Natal? 
 selection and appraisal of data from primary research 
 
The criteria for inclusion of research articles in the meta-study were that:  
 the focus of research was on HIV positive people receiving ART (their feelings, concerns, 
needs and problems) 
 the research design was qualitative 
 
The studies included in the meta-study were located through searching literature databases 
such as:  
 Medsearch 
 CINAHL 
 PsychInfo 
 Pubmed  
 Google 
 
The search terms used included: 
 HIV 
 AIDS 
 ARVs 
 PLWHA experiences, qualitative  
 
The search was restricted to articles written in English, and efforts were made to include a 
variety of qualitative methods used to conduct the studies. Some articles were excluded, but 
the nature of the qualitative designs was not an exclusion criterion. The quantitative studies 
were excluded and only qualitative research studies focusing on PLWHA undergoing ART 
were included. 
 dissemination of the findings of the meta-study (Paterson et al, 2001: 13) 
 
3.2.2  Phase Two:  The Experiences of Clients on ART 
The phenomenological research method was used to conduct phase two of the study. 
Phenomenology is an approach to exploring and understanding people’s everyday life 
experiences. Topics appropriate to phenomenology are ones that are fundamental to the life 
experiences of humans. The goal of phenomenological inquiry is to understand fully lived 
experiences and the perceptions to which it gives rise (Polit & Beck, 2008:227). There are a 
number of variants and methodological interpretations of phenomenology. The two main 
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schools of thought are descriptive phenomenology and interpretive phenomenology 
(hermeneutics).  
 
A descriptive phenomenological research approach was used to describe the experiences as 
they were lived by the participants. Polit and Beck (2008:228) further state that descriptive 
phenomenologists insist on the careful description of ordinary conscious experience of 
everyday life, a description of  ‘things’ as people experience them. In this study the participants 
were asked to share their real life stories about the journey from getting tested for HIV, living 
with HIV and accessing treatment, through to starting and continuing with ART. This included: 
 Personal experiences , such as adjusting to being HIV positive, living with illness, fears, 
hopes and secrecy 
 Relationships with society, such as the reactions of family, friends, colleagues, neighbours, 
the wider community, and sexual partners 
 Attitudes of health providers, such as doctors, nurses, pharmacists, and CHW 
 Experiences with health services, such as clinics, hospitals, laboratories and pharmacies. 
 
The descriptive phenomenological approach was found to be the relevant method to conduct 
this study because the researcher’ interest was on the real life experiences of PLWHA, 
particularly those taking ART. 
 
3.2.2.1 Target population and selection of participants 
The study was conducted in the eThekwini district in KZN. The district was chosen because of 
the number of clinics rolling out ART. Three institutions initiating ART participated in the study; 
one urban, one semi-urban and one rural clinic, to ensure adequate representation of each 
group. Participants were recruited from two initiating hospitals and one Community Health 
Centre providing ART.  
 
The number of participants was determined by the number of persons required to permit an in-
depth exploration and obtain a clear understanding of the phenomenon of interest from various 
perspectives. Twelve participants were interviewed, and interviews were stopped when data 
saturation was achieved (no new themes or essences emerging from participants and data 
beginning to repeating itself).  
 
Purposive sampling was used to select study participants.  This is the most common type of 
sampling utilized in phenomenology, since the purpose of this type of research is to accentuate 
specific information, and not to generalize findings (Streubert, 2003:342). Generally, a 
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purposive sample is comprised of respondents who are likely to be able to provide information 
about the phenomenon under investigation (Burns & Grove, 2005: 352).  
 
In phenomenology the guiding principle in selecting a sample is that all participants must have 
experienced the phenomenon, and must also be able to articulate what it is like to have lived 
that experience. Polit and Beck (2008:358) state that phenomenologists use a criterion 
sampling method, the criterion being experience with the phenomenon under study. In this 
study the sample was targeted to represent HIV positive clients who were taking ART as their 
chronic medication in selected public health clinics and the predetermined criterion of 
importance was living with HIV and taking antiretroviral medication. 
 
Clients were selected irrespective of gender, age and socio-economic status. The criteria for 
including interviewees in the study were that they should be: 
 HIV positive and receiving ART 
 Attending different clinics receiving HIV and AIDS related care from the public sector 
 Clients were to be selected from public sector clinics with rural, urban and semi urban 
characteristics, irrespective of the clinical stage of the disease or the length of time they 
were on ART 
 Over 18 years of age, but within the reproductive age 
 Able to give informed consent to the interview 
Zulu speaking as interviews were conducted in IsiZulu. 
 
3.2.2.2 Data collection 
A semi-structured interview guide was used for data collection and the primary data collection 
strategy was the use of a tape-recorder, but the practice of note-taking during personal 
interviews was also utilised, in order to capture any non-verbal cues.  
 
Interviews took place in private rooms in the antiretroviral clinics of the initiating hospitals, so 
that each participant could share his or her experiences freely. Participants were asked to 
suggest the date and time suitable for the interview. The participants were contacted prior to 
the formal session to solicit their interest, address the nature of the study, provide an overview 
of the informed consent and give them time to reflect on the phenomenon of the study.  
 
It was anticipated that the period of reflection would enable richer descriptions during the 
interview (Streubert, 2003: 344). This meant that participants would be more willing to share 
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their experiences about their condition and the service they received after being given time to 
think about the study. 
 
3.2.2.3 Bracketing  
Bracketing is the cognitive process of putting aside one’s own beliefs, not making judgments 
about what one has observed or heard, and remaining open to data as they are revealed. In 
descriptive phenomenology, this activity is carried out before the beginning of the study and is 
repeated throughout data collection and analysis (Streubert, 2003:25).  
 
Before collecting data the researcher explored her own preconceived notions or ideas about 
HIV positive people and a conscious effort was made to set these preconceptions aside during 
data collection and analysis. This enabled the researcher to remain neutral with respect to 
belief or disbelief about the phenomenon. Setting aside previous knowledge or personal beliefs 
about the phenomenon under investigation prevented these from interfering with the recovery 
of a pure description of the phenomenon   
 
3.2.2.4 Data analysis 
Data analysis included four steps as outlined by Streubert (2003:346). These were: 
1. Carefully reading the interview transcripts in order to obtain a general sense of the 
experience 
2. Reviewing the transcripts to uncover essences 
3. Apprehending essential relationships 
4. Developing a formalized, exhaustive description of the phenomenon 
 
The first step involved reading the transcripts while listening to the audiotapes so that the 
accuracy of the transcripts could be verified. At that stage the researcher began “dwelling in 
the data”. Streubert (2003:346) describes “dwelling in the data” as "the time and reflection 
committed to reading the interviews over and over and becoming immersed in their content.” 
This process is also called immersion. 
 
The second step was reviewing the transcripts in order to uncover the essences, a process 
also known as “immersion”. The field notes were transcribed by listening carefully to the tape 
recorder to ensure accuracy of transcription. The qualitative data consisted of transcribed 
interviews with twelve clients, eight women and four men, sharing their experiences on living 
with HIV and being on ART.  Each transcript ranged from eight to ten pages that had to be 
read, re-read, and then organized, integrated and interpreted. Transcriptions were done on the 
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same day as the interview to prevent a backlog; this was also important as each interview 
informed and led to slight alterations in the line of questioning for the next interview. These 
were transferred to and stored in a Word document on the computer. 
 
During the third step, apprehending essential relationships, the themes were related to one 
another. This led to the final step of developing a formalized, exhaustive description of a 
phenomenon. The exhaustive description was the result of the researcher’s analysis of the 
data and the inter-relationship of themes to one another, resulting in a formalized view of the 
phenomenon. 
 
3.2.2.5 Trustworthiness 
“Trustworthiness” is the term used to demonstrate rigor in qualitative research, which, in any 
research, is required to prevent errors of either a constant or intermittent nature (Morse & 
Field, 2002:118). Steps were taken while in the field to demonstrate trustworthiness of data, to 
confirm that the findings accurately reflected the experiences and viewpoints of participants, 
rather than perceptions of the researcher. As stated by Polit and Beck (2008:71), one 
confirmatory activity involves going back to participants and sharing preliminary interpretations 
with them so that they can evaluate whether the researcher’s thematic analysis is consistent 
with their experiences. Accordingly, to confirm credibility of findings, the participants were re-
visited to share the interview transcripts with them. During these returns to the antiretroviral 
sites the transcripts were given to the interviewees to read in order to establish if they agreed 
with what was recorded as their experiences. Credibility was established as the participants 
were in agreement with recorded information to be true of their experiences. 
 
Dependability was ensured by careful transcription and analysis of data manually, and also by 
careful description of the decisions made during analysis of data; reliability was further 
enhanced by openness to the creation of new themes as these emerged from the data. 
 
3.2.3 Phase Three: The Experiences of Health Care Providers Rendering Antiretroviral  
Services 
 
During this phase in-depth interviews were carried out with health care providers working in the 
ARV clinics where the study was conducted. Only those health care providers who agreed to 
participate were interviewed. Health care providers irrespective of category were recruited to 
participate in the study.  
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3.2.3.1 Selection of participants 
Health care providers from three initiating clinics with rural, urban and semi-urban 
characteristics participated in the study. For the clinics to be included in the study they had to 
be public health clinics, providing comprehensive management of HIV and AIDS, care, 
treatment and support. Purposive sampling was used to select health care providers. The 
health care providers were chosen on the grounds of working with PLWHA on ART and for 
their knowledge of and experience in management of HIV positive people on ART. Only those 
health care providers who agreed to participate were interviewed, irrespective of the category. 
At least one professional nurse in three of the four clinics was interviewed, and a counsellor 
trained in adherence counselling for ART was also interviewed.  
 
3.2.3.2 Data collection 
Open-ended questions were asked in order to allow the health care providers to share their 
experiences in working with HIV positive clients, especially those receiving ART, more freely. 
The interview was started by asking the question “Tell me about your experiences in working 
with HIV positive people receiving ART”, and responses were tape- recorded after permission 
had been granted to do so. 
  
3.2.3.3 Bracketing 
Before collecting data the researcher explored her own preconceived notions and ideas about 
working with HIV-positive people, and these preconceptions were rigidly set aside during data 
collection and analysis. This enabled the researcher to remain neutral with respect to beliefs or 
disbeliefs about the phenomenon. Setting aside previous knowledge or personal beliefs about 
the phenomenon under investigation prevented these from interfering with the recovery of a 
pure description of the phenomenon (Annexure 11).   
 
3.2.3.4 Data analysis 
The interviews from participants were recorded on an audiotape, and there were notes were 
also made by the interviewer.  
 
The first step of the data analysis involved writing the transcripts while listening to the 
audiotapes in order to verify accuracy, and was done on the same day as the interview to 
prevent a backlog; the same-day transcription was also important as each interview informed 
and led to slight alterations in the line of questioning for the next interview. These were typed 
into and stored on a Word document on the computer, and this as well as a hard copy 
(transcribed and fully translated into isiZulu) for each interview was kept. 
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The second step entailed reviewing the transcripts to uncover the essences: a sentence by 
sentence review to identify these. During the third step the themes were related to one 
another.  
 
This led to the final step of developing a formalized, exhaustive description of a phenomenon. 
This description was the result of the researcher’s analysis of the data and the inter-
relationship of themes to one another, resulting in a formalized view of the phenomenon. In-
depth analysis commenced after saturation had been achieved. 
 
3.2.3.5 Trustworthiness 
The preliminary interpretations were shared with participants to confirm the credibility of 
findings, and transcripts of the interviews were given to health care providers on subsequent 
visits to review. The participants recognized the researcher’s findings to be consistent with 
their experiences and that meant credibility was established. 
 
3.3  ETHICAL CONSIDERATIONS 
3.3.1 Permission to Undertake Research Study 
Approval to conduct the study was obtained from the Postgraduate Committee of the 
University of the Witwatersrand (Annexure One), and ethical clearance was obtained from the 
Human Research Ethics Committee (Medical) of the University of the Witwatersrand 
(Annexure Two). Permission was sought from the district manager of eThekwini district to gain 
access to the clinics, as well as to interview health providers. The facility managers were also 
informed about the study to gain their cooperation to release the participants during the 
interviews. 
 
Measures were also taken to ensure confidentiality: the names of health care providers who 
participated in the study were not disclosed, and nowhere in the research report were clinics 
identified by their names, being rather identified by codes like “clinic A” for reporting purposes 
All health care providers who agreed to participate were asked to sign an informed consent. 
 
Permission to use audiotapes during interviews was sought, and acquired. Audiotapes shall be 
kept for two years post publication, or for six years if not published for audit purposes (SA 
National Health Act). Data was stored in a locked filing cabinet, and no one had access to it 
except for the interviewers. Consent was viewed as an ongoing transactional process because 
there was no way to know exactly what might transpire during each interview. 
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3.3.2  Confidentiality 
Participants were assured that information shared with the interviewer would remain 
confidential: names and addresses would not be disclosed; a code number was used to 
identify clinics; and data was stored in a locked filing cabinet. A codebook containing both the 
code numbers and names and addresses of informants were stored in a locked file separate 
from all other data, and informants were assured that their identities would not be revealed. 
Any publications resulting from these data will not contain identifying information.  
 
These issues were discussed with all participants before the interviews began. Participants 
were asked to sign a form indicating that the interviewee had given written consent, and a 
private venue was arranged within the clinic for the interviews to take place.  
 
3.3.3 Informed Consent 
An information sheet about the study was drawn up, in which its risks and benefits were 
explained, and this was read to the recruited participants (Annexures Three and Four). 
Participation was entirely voluntarily and those recruited were assured that declining would in 
no way influence their present and future health care.  
 
Written consent was obtained from participants (Annexure Five), and the participants’ identity 
and personal details were protected by assigning a code number for the interview.  
 
Attempts were made to ensure that the setting where interviews were done was quiet and 
confidential, and that the researcher was aware that sharing experiences about living with HIV 
was a sensitive subject. Efforts made to phrase the questions tactfully and were sensitive to 
cultural and linguistic diversity.  
 
Participants were initially addressed in a group setting at the ARV clinic in order to explain the 
research study, and those clients who were comfortable in proceeding to interviews were 
invited into a private room to ensure respect for human dignity. 
 
3.3.4 Rights of Participants 
Participants were given a copy of the information sheet to read after a full explanation was 
given to them, which included the telephone and fax numbers of the researcher, as well as a 
statement informing them that they could withdraw from the study at any time.  
A consent form (Annexure Five) was designed for the participants to sign after permission has 
been sought and acquired to tape-record the interviews. 
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3.4  CONCLUSION 
The findings from all of the phases were investigated, and patterns of convergence were 
identified which helped to confirm findings deduced from other data, literature and the 
Continuum of Care approach which is the framework underpinning the study. In Annexure 11, 
the researcher described her own experiences regarding her involvement with clients on ART 
and the health care providers of ART services. 
 
In chapter four the description of data follows, with reflection on participants and the interviews. 
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CHAPTER 4 
 4. RESULTS OF THE STUDY 
 
4.1 INTRODUCTION 
The aim of this chapter is to describe the results of the study. This chapter presents an 
analysis and discussion of data collected through multiple phases, and using qualitative 
enquiry methods for collection. The results are described according to the different phases of 
the study.  
 
Phase one entails a description of how the metasynthesis of qualitative research articles on 
HIV-positive patients on ART was done.  
Phase two of the study includes the results of the experiences of clients on ART.  
Phase three describes the findings of the experiences of health providers rendering ART 
services 
 
4.2 PHASE ONE: METASYNTHESIS OF QUALITATIVE RESEARCH ARTICLES ON HIV AND 
AIDS PATIENTS ON ARV THERAPY 
 
The aim of conducting a metasynthesis was to study the feelings, concerns, needs and 
problems of HIV-positive people using evidence-based qualitative research methods. Ten 
qualitative studies were synthesized using Paterson’s (2001:13) method: 
 Formulating a research question 
 Selection and appraisal of primary research 
 Meta-data-analysis 
 Meta-method 
 Meta-theory 
 Metasynthesis 
 
This method is presented diagrammatically in figure 4.1 below. Thereafter each step is 
described and explained with tables. 
39 
 
 
 
 
Figure 4.1:  Metastudy Process 
Source: Paterson, Thorne, Canam & Jillings (2001) 
 
4.2.1 Selection and Appraisal of Primary Research 
Qualitative studies published from 1998 to 2007 were selected for this review if they focused 
on clients’ experiences with HIV and AIDS, ART and adherence to ART. Characteristics of 
studies included in the metasynthesis were considered. These included  
 the country of research 
 sampling methods used 
 sample size 
 recruitment strategy 
 research design 
 data collection methods 
 data analysis procedures and results 
 
These characteristics are presented in Table 4.1.  
 
 
 
 
 
 
Primary Qualitative Research 
Research 
Findings 
Research Methods Theoretical & Analytical 
Frameworks 
Meta-Data- 
Analysis 
Meta- Method Meta-Theory 
Meta-synthesis 
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Table 4.1:  Characteristics of Studies included in Metasynthesis  
 
Author/ Year Country Sampling Method Sample Size 
Recruitment of 
Respondents 
Research 
Design 
Data 
Collection 
Data 
Analysis Results 
Vervoort, 
Borleffs, 
Hoepelman and 
Grypdonck 
(2007) 
Netherlands Electronic 
database 
indexes: 
CINAHL, 
PUBMED and 
Web of 
Sciences 
Qualitative 
studies 
published from 
1996 to April 
2005 
Through HIV and 
AIDS clinics, 
treatment centres 
and community 
organisations. 
Flyers & Posters, 
direct invitation 
Descriptive 
Qualitative 
In-depth 
interviews, 
diaries, 
focus 
interviews 
Reading 
publications 
several times 
Findings 
coded 
inductively  
Articles 
organized into 
themes 
Themes: 
Therapy related factors 
Condition related 
factors 
Patient related factors 
Health care team  and 
system related factors 
Socio-economic factors 
Sidat, Fairley 
and Grierson 
(2007) 
Australia Purposive 
sample of 
seven men and 
three women 
Ten 
participants 
 
Direct invitation 
by clinicians on 
routine clinical 
appointment 
Phenomeno-
logy 
Qualitative 
In-depth 
interviews 
Guided by 
Giorgi’s 
phenomeno-
logical method 
Listening of 
tapes 
Units of 
meaning were 
identified 
 
Themes  
HAART as life-saving 
option 
Rapid improvement of 
clinical condition 
Difficulties  coping with 
being HIV infected 
Psychological and 
emotional implications 
of treatment 
Clinician-patient 
relationship issue 
Managing side effects 
Rajabiun, 
Mallinson, 
McCoy, 
Coleman, 
Drainoni, 
Rebholz and 
Holbert (2007) 
 USA Purposive 
sampling 
Seventy six 
HIV positive 
participants 
Recruited from 
seven community 
& clinic sites 
Qualitative In-depth 
interviews 
Transcribed 
verbatim 
Codes 
QSR Nvivo 
Software 
version 2.0 
Themes: 
Level of acceptance of  
HIV 
Coping with stigma 
Health care provider 
relationships 
Presence of external 
support 
External barriers to care                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
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Table 4.1: continued 
Author/ Year Country Sampling Method Sample Size 
Recruitment of 
Respondents 
Research 
Design 
Data 
Collection 
Data 
Analysis Results 
Edwards (2006) USA Purposive 
sample 
Thirty three 
participants, 
African 
American 
female 
receiving HIV 
care at the 
clinic 
Recruited from 
outpatient clinic 
through physician 
networks and 
posted flyers 
Qualitative 
Exploratory 
Interviews 
Journaling 
Transcribed 
verbatim and 
coded 
Main themes 
organized 
Themes 
1.Barriers to adherence:  
HIV/AIDS related 
stigma,  
Feeling unloved and 
uncared for 
Relationship turbulence,  
Being married to an 
HIV-positive partner 
2. Facilitators of  
adherence 
Supportive family 
Presence of young 
children 
Kumarasamy, 
Safren, 
Raminani, 
Pickard, James, 
Krishnan, 
Solomon and 
Mayer (2005) 
India Purposive 
sampling 
Sixty 
participants 
receiving HIV 
care 
Recruited by 
clinician during 
routine 
appointment 
Formative 
Qualitative 
In-depth 
interviews 
-Verbatim 
transcripts of 
audiotapes 
read  several 
times, 
developed 
coding 
system 
 
-NVIVO 
software 
Themes related to 
barriers of adherence: 
Cost, social support 
system, stigma 
concerns, perceived 
benefits of  non-
adherence 
Mabunda (2004) USA Convenient 
sample 
Thirteen key 
informants 
(HIV positive) 
and fifteen 
general 
informants 
(carers for HIV 
positive people 
and key  
figures in 
community) 
Recruited from a 
support group 
meeting and 
through ‘snowball’ 
method 
Qualitative 
Grounded 
theory 
Observations 
In-depth 
interviews 
Verbatim 
transcripts of 
tapes 
Patterns and 
themes 
identified and 
compared 
daily 
Themes 
 Support group meetings 
Acceptance of HIV and 
ability to cope 
Positive attitude toward 
life 
Ties with extended 
families, reluctant to 
disclose for fear of 
losing relationships 
42 
 
 
 Table 4.1: continued 
Author/ Year Country Sampling Method Sample Size 
Recruitment of 
Respondents 
Research 
Design 
Data 
Collection 
Data 
Analysis Results 
Black and Miles 
(2002) 
North Carolina 
USA 
Randomization
- was part of a 
large clinical 
trial 
Forty eight 
African 
American 
women HIV 
positive 
Recruited in two  
infectious disease 
clinics and 
community 
agencies 
Qualitative  
Descriptive 
Telephonic  
interviews, 
observations 
during home 
visits 
Content 
analysis and 
constant 
comparison 
used to 
analyse field 
notes 
Themes 
Feelings of shame about 
having HIV 
Need for support and 
tangible assistance 
Stigmatization by 
community following 
disclosure 
Stigmatizing 
experiences with health 
care professionals 
Golin, Isasi, 
Bontempi and 
Eng (2002) 
North Carolina 
USA 
Convenient 
sample 
Twenty four 
HIV positive 
patients  
 
Recruitment by 
providers in 
clinics 
Qualitative Focus group 
discussions 
Audiotapes 
transcribed 
Content 
analysis of 
each 
transcript 
Themes 
Patient beliefs about 
ART 
Struggles integrating 
complex regimens into 
daily routine 
 Role of relationship with 
health care 
professionals 
Marcenko and 
Samost 
(1999) 
 
USA 
- Six focus 
groups 
Agency staff, 
social worker, 
flyers 
Exploratory  
Qualitative 
Focus Group Audiotapes 
transcribed 
Categories/ 
themes 
related to 
research 
question 
identified 
 
Themes: 
Disclosure (who, when 
& what to  share) 
Spirituality, Positive 
thinking, Inner strength 
(coping mechanisms) 
Future planning 
Diagnosis- providers not 
trained to disclose 
results 
Lack of confidence in 
medical knowledge & 
treatment regimes-
adherence was low 
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Table 4.1: continued 
Author/ Year Country Sampling Method Sample Size 
Recruitment of 
Respondents 
Research 
Design 
Data 
Collection 
Data 
Analysis Results 
Metcalfe, 
Langstaff, 
Evans, Paterson 
and Reid (1998) 
Canada Convenient 
sample 
Eight HIV 
positive 
women 
Recruited by 
distributing 
information letters 
to women who 
visited the facility 
Qualitative 
Phenomenolo
gy 
Interviews, 
personal and 
telephonic 
 Themes 
Initial diagnosis of shock 
after knowing HIV status 
Social support from 
families and support 
group 
 Support from health 
care professionals 
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4.2.2  Meta Data Analysis 
The data-analysis methods used in all the selected studies were reviewed, and are 
presented in Table 4.2 below. The most commonly used data analysis method across 
authors was developing data organisation, coding and organization of themes. 
 
Table 4.2:  Data Analysis Methods used in Studies included in Metasynthesis 
Author/ Year Data Analysis Method 
Vervoort, Borleffs, Hoepelman and 
Grypdonck (2007) 
Reading publications several times 
Findings coded inductively  
Articles organized into themes 
Sidat, Fairley and Grierson (2007) 
Guided by Giorgi’s phenomenological method 
Listening of tapes 
Units of meaning were identified 
Rajabiun, Mallinson, McCoy, Coleman, 
Drainoni, Rebholz and Holbert (2007) 
Codes 
QSR Nvivo Software version 2.0 
Edwards (2006) Transcribed verbatim and coded Main themes organized 
Kumarasamy, Safren, Raminani, 
Pickard, James, Krishnan, Solomon and 
Mayer (2005) 
Verbatim transcripts of audiotapes read  several 
times, developed coding system 
NVIVO software 
Mabunda (2004) 
Verbatim transcripts of tapes 
Patterns and themes identified and compared 
daily 
Black and Miles (2002) Content analysis and constant comparison used to analyse field notes 
Golin, Isasi, Bontempi and Eng 2002) Content analysis of each transcript 
Marcenko andSamost(1999) 
Audiotapes transcribed 
Categories/ themes related to research question 
identified 
Metcalfe, Langstaff, Evans, Paterson 
and Reid (1998) Not described 
 
4.2.3 Meta Theory 
An appraisal of commonly used theories in the selected studies was done. Most authors 
were using the grounded theory approach, except for one who used the systems theory. In 
the five studies reviewed, there was no explicit mentioning of theories used (Table 4.3). 
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Table 4.3:  Theories used in Studies included in Metasynthesis 
Author/Year Theories Used 
Vervoort, Borleffs, Hoepelman and Grypdonck (2007) Grounded theory 
Sidat, Fairley & Grierson (2007) - 
Rajabiun, Mallinson, McCoy, Coleman, Drainoni, Rebholz and Holbert 
(2007) Grounded theory 
Edwards (2006) Grounded theory 
Kumarasamy, Safren, Raminani, Pickard, James, Krishnan, Solomon 
and Mayer (2005) - 
Mabunda (2004) Grounded theory 
Black and Miles (2002) - 
Golin, Isasi, Bontempi and Eng (2002) - 
Marcenko and Samost(1999) Systems theory 
Metcalfe, Langstaff, Evans, Paterson and Reid (1998) - 
 
4.2.4 Metasynthesis 
A list of key metaphors/themes was made for each of the studies, and the list juxtaposed. 
The juxtaposition of themes is reflected in Table 4.4. After reviewing each study in-depth, 
the decision was made that all studies were directly comparable as reciprocal translations, 
that is, there was mutual agreement amongst studies. The metasynthesis revealed a 
shared set of four themes that increase understanding of experiences of PLWHA. The 
following themes were identified:  
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Table 4.4: Metaphors Used to Construct Reciprocal Translations 
Theme Metcalfe, 
Langstaff 
et al 
(1998) 
Marcenko 
and 
Samost 
(1999) 
Golin, Isasi, 
Bontempi 
and Eng 
(2002) 
Vervoort, 
Borleffs, 
Hoepelman 
and 
Grypdonck 
(2007) 
Sidat, Fairley 
and Grierson 
(2007) 
Black and 
Miles 
(2002) 
Mabunda 
(2004) 
Kumarasamy, 
Safren et al. 
(2005) 
Edwards 
(2006) 
Rajabiun, 
Mallinson et 
al. (2007) 
Acceptance 
and Coping 
mechanisms 
Shock 
and anger 
initially 
Coping 
became 
more 
effective 
as the 
length of 
time since 
diagnosis 
Spirituality 
, prayer & 
faith   
Own inner 
strength 
Positive 
thinking 
_ _ Difficulties 
coping  with 
being “HIV- 
infected 
“Psychological 
& emotional 
Stress 
Faced with 
feelings of 
shame 
about 
having HIV 
Admitting 
HIV status 
so as to 
move 
forward 
with life, 
“Denying 
HIV status 
is denying 
life” 
Positive 
attitude 
towards life  
_ Desire to feel 
loved and 
cared for 
Emotional 
support, 
affirmations 
and 
reassurances 
reduce stress 
levels and 
fear 
Coping with 
HIV status 
influenced by 
level of 
acceptance 
of HIV status 
Spirituality 
helps 
develop 
feelings of 
self worth 
and gain 
acceptance 
of disease 
Social 
support and 
Disclosure 
Gained 
support 
from 
family, 
however 
family not 
always 
aware of 
relative’ 
HIV 
status 
Friends, 
family 
Formal 
support 
group 
Amount of 
support 
correlated 
with 
comfort to 
share 
diagnosis 
Hiding HIV 
status from 
family, 
friends & 
partners due 
to fear of 
discrimination 
and isolation 
Non-
disclosure 
due to fear of 
stigmatization, 
discrimination 
and isolation 
_ Need for 
support 
and 
tangible 
assistance 
Disclosure- 
the goal 
was to 
disclose 
diagnosis 
in the  
situations 
where risk 
was 
minimized 
and 
benefits 
maximized 
Importance 
of 
relationship 
with 
extended 
family 
Valued 
their ties 
with 
extended 
family 
Reluctant 
to disclose 
for fear of 
losing 
relationship 
Lack of social 
support 
Fears of 
rejection, 
alienation and 
stigma from 
family, friends 
and 
community 
Disclosure 
resulting in 
negative 
consequences 
Social 
support 
essential 
component 
for daily 
survival 
Supportive 
family 
members, 
Stigma noted 
as a social 
barrier 
Young 
children as 
primary 
source of 
social 
support 
External 
support from 
friends, 
partners and 
family as 
ongoing 
motivators for 
care. 
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Table 4.4: Continued 
Theme Metcalfe, 
Langstaff et 
al 
(1998) 
Marcenko 
and Samost 
(1999) 
Golin, Isasi, 
Bontempi 
and Eng 
(2002) 
Vervoort, 
Borleffs, 
Hoepelman 
and 
Grypdonck 
(2007) 
Sidat, 
Fairley and 
Grierson 
(2007) 
Black and 
Miles 
(2002) 
Mabunda 
(2004) 
Kumarasamy, 
Safren et al. 
(2005) 
Edwards 
(2006) 
Rajabiun, 
Mallinson 
et al. (2007) 
Experiences/ 
Beliefs  
about HIV  
medication 
_ Numerous 
side effects 
from 
prescribed 
medications 
Conviction for 
healing 
properties of 
own remedies 
Treatment life 
saving yet 
stigmatizing 
Struggles 
integrating 
complex 
regimens into 
daily activities 
Basic 
activities 
(sleeping, 
eating and 
working) 
seen as 
barriers to 
taking 
medicine 
Allows people 
to live longer, 
Experience 
side effects,  
Belief that 
skipping doses 
give body time 
to rid itself of 
medication 
and recover 
from side 
effects, 
Demands of 
medication 
based on strict 
rules and 
complexities of 
regimen 
Life saving 
HAART 
Current 
treatment 
regimens 
well suited 
for their 
lifestyles 
Diverse side 
effects 
related to 
HAART 
_ _ _ Despite 
challenges 
participants 
followed 
their HIV 
medication 
regimens 
Optimistic 
about 
treatment, 
reported 
desire to be 
updated and 
informed 
about new 
treatment 
Health Care 
provider 
relationship/ 
health 
system 
factors 
Significant 
amount of 
support from 
health care 
professionals 
Lack of trust 
Disrespectful 
,insensitive 
and unhelpful 
Abrupt, 
judgemental 
and 
confrontational 
Open, non-
judgemental 
conversations  
Supportive 
relationships  
Supportive 
health care 
providers  
Caring attitude 
Effective , 
frank 
communication  
-Optimal 
relationships 
with health 
providers 
Stigmatized 
interactions 
with health 
care 
professional 
Participants 
lacked 
adequate 
knowledge 
about HIV 
and AIDS 
until they 
joined a 
support 
group 
 
 
 
  
Non-caring 
attitude and 
no respect 
“They degrade 
us and shame 
us , they make 
us feel bad” 
_ Strong, 
healthy 
positive 
relationships 
with 
provider 
facilitate 
continuity 
with medical 
care and 
vice versa 
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Table 4.5:  Derived Themes from Concepts in Original Studies 
Derived Theme Authors Original Concepts 
Acceptance & Coping 
mechanisms 
Rajabiun, Mallinson et al. (2007) Coping with HIV status is influenced by level of acceptance of HIV status Spirituality helps develop feelings of self worth and gain acceptance of disease 
Sidat, Fairley and Grierson (2007) Difficulties coping  with being “HIV- infected” Psychological & emotional Stress 
Edwards (2006) Desire to feel loved and cared for Emotional support, affirmations and reassurances reduce stress levels and fear 
Mabunda (2004) Admitting HIV status so as to move forward with life, “Denying HIV status is denying life” Positive attitude towards life 
Black and Miles (2002) Faced with feelings of shame about having HIV 
Marcenko and Samost (1999) 
Spirituality , prayer & faith   
Own inner strength 
Positive thinking 
Metcalfe, Langstaff et al (1998) Shock and anger initially Coping became more effective as the length of time since diagnosis 
Social support & 
Disclosure 
Rajabiun, Mallinson et al. (2007) External support from friends, partners and family as ongoing motivators for care. 
Vervoort, Borleffs, Hoepelman and 
Grypdonck (2007) Non-disclosure due to fear of stigmatization, discrimination and isolation 
Edwards (2006) 
Social support essential component for daily survival 
Supportive family members, Stigma noted as a social barrier 
Young children as primary source of social support 
Kumarasamy, Safren et al. (2005) 
Lack of social support 
Fears of rejection, alienation and stigma from family, friends and community 
Disclosure resulting in negative consequences 
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Table 4.5: Continued 
Derived Theme Authors Original Concepts 
Social support & 
Disclosure 
Mabunda (2004) 
Importance of relationship with extended family 
Valued their ties with extended family 
Reluctant to disclose for fear of losing relationships 
Black and Miles (2002) 
Need for support and tangible assistance 
Disclosure- the goal was to disclose diagnosis in the  situations where risk was minimized 
and benefits maximized 
Golin, Isasi, Bontempi and Eng 
(2002)                                          Hiding HIV status from family, friends & partners due to fear of discrimination and isolation 
Marcenko and Samost (1999) 
Friends, family 
Formal support group 
Amount of support correlated with comfort to share diagnosis 
Metcalfe, Langstaff et al.  
(1998) Gained support from family, however family not always aware of relative’ HIV status 
Experiences/ Beliefs  
about HIV  
Medication 
 
Rajabiun, Mallinson et al. (2007) Optimistic about treatment, reported desire to be updated and informed about new treatment 
Sidat, Fairley and Grierson (2007) 
Life saving HAART 
Current treatment regimens well suited for their lifestyles 
Diverse side effects related to HAART 
Vervoort, Borleffs, Hoepelman and 
Grypdonck (2007) 
Allows people to live longer, Experience side effects,  
Belief that skipping doses give body time to rid itself of medication and recover from side 
effects, Demands of medication based on strict rules and complexities of regimen 
Edwards (2006) Despite challenges participants followed their HIV medication regimens 
Golin, Isasi, Bontempi and Eng 
(2002)                                          
Treatment life saving yet stigmatizing 
Struggles integrating complex regimens into daily activities 
Basic activities (sleeping, eating and working) seen as barriers to taking medicine 
Marcenko & Samost (1999) Side effects from prescribed medications, Conviction for healing properties 
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4.2.4.1 Acceptance of and coping with HIV positive status 
There was consistency amongst authors that HIV infected people have difficulty coping with 
the disease (Rajabiun & Mallinson et al. 2007; Sidat, Fairley & Grierson 2007; Edwards 
2006; Mabunda 2004; Black & Miles 2002; Marcenko & Samost 1999; Metcalfe; Langstaff; 
Evans; Paterson & Reid 1998). Sidat, Fairley and Grierson (2007) further explain that HIV 
infection poses serious psychological and emotional stress; there is a need for emotional 
support and reassurance in order to reduce these high stress levels. Marcenko and Samost 
(1999) reported that spirituality, faith and prayers contribute to acceptance of living with 
HIV, whilst Mabunda (2004) claimed that a ppositive attitude towards life increases coping 
mechanisms.  
 
4.2.4.2 Social support and disclosure 
There was strong agreement across studies that while PLWHA need support from 
significant others (family, partners and friends), disclosure remains a challenge (Rajabiun & 
Mallinson et al 2007; Vervoort, Borleffs, Hoepelman & Grypdonck 2007; Edwards 2006; 
Kumarasamy, Safren, Raminani, Pickard, James, Sri Krishnan, Solomon & Mayer 2005; 
Mabunda 2004; Black & Miles 2002; Golin, Isasi, Bontempi & Eng 2002; Marcenko & 
Samost 1999; Metcalfe, Langstaff et al 1998). There was concern regarding whom to 
disclose the diagnosis to, as well as the question of when and how. Reasons for non-
disclosure were categorized as follows: 
 Disclosure to family members: fear of rejection and negative reactions, (Kumarasamy et 
al. 2005). 
 Disclosure to friends: fear of alienation and stigmatization (Kumarasamy et al 2005).  
 Disclosure to the community: fear of discrimination and isolation. (Vervoort et al. 2007; 
Kumarasamy et al. 2005 and Golin et al. 2002).  
 
PLWHA highlighted stigma as a social barrier, and Vervoort et al. (2007) confirms this by 
stating that “most HIV-infected patients do not disclose their HIV diagnosis fearing 
stigmatization, discrimination and isolation”. 
 
4.2.4.3 Experiences of and beliefs about HIV medication  
Sidat et al. (2007), Vervoort et al. (2007) and Golin et al. (2002) were in agreement that 
although PLWHA perceive HIV medication as life-saving there were concerns about side 
effects and the demands of medication (based on the complexities of the regimens). 
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4.2.4.4 Health care provider relationships/health system factors 
Significant amount of support from health care providers was shared by studies. Highlights 
of non-judgemental and caring attitudes were made (Sidat et al. 2007, Vervoort et al. 2007, 
Rajabiun et al. 2007 and Golin et al. 2002 & Metcalfe et al. 1998), and ppositive 
relationships with providers were mentioned as motivators for continuity of care. However, 
Marcenko and Samost (1999) highlighted the negative aspects of less-than-satisfactory 
relationships, including disrespectful; insensitive; confrontational and non-caring attitudes, 
as well as the lack of trust from practitioners. Doctors and providers displaying these 
positions were described as being abrupt, not answering questions comprehensively, and 
making clients wait for long periods of time before attending to them. 
 
4.3  PHASE TWO: THE EXPERIENCES OF CLIENTS ON ART 
A semi-structured interview guide was used as a source of data collection to explore the 
experiences of clients receiving ART in public sector initiating clinics. Data was collected 
over a period of four months, and a total of twelve clients receiving ART in the initiating 
clinics of eThekwini district were interviewed for the study. After interviewing the tenth 
participant, data saturation was reached. Data saturation was confirmed by interviewing two 
more clients.  
 
4.3.1 Size of the Sample Interviewed 
Eight women and four men agreed to be interviewed, all of whom were unmarried, with an 
age range from 26 to 42 years.  Although most clients had children who were alive and 
well, many had also experienced the death of their babies.  
 
Table 4.6 below presents the number of clients who participated in interviews in the three 
participating institutions. 50% of the interviewees were from clinic A, which was the first 
clinic to participate in interviewing. 
 
Table 4.6: Sample of Clients interviewed During Phase Two in the Three  
Participating Clinics 
Clinic Frequency Percent 
A 6 50 
B 3 25 
C 3 25 
Total 12 100 
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4.3.2 Main Themes of the Interviews 
Table 4.7 depicts the main themes that emerged from the interviews and these themes 
outline the information provided during the interviews. Each participant is identified by the 
code and the line number of his or her words in the transcript, e.g. 3:298, that is, participant 
3 line number 298. The important concerns expressed by the participants are highlighted in 
the analysis. In practice the themes are strongly linked to each other and as such, some 
repetition of key points was unavoidable. 
 
Table 4.7: Main Themes in the Participants Words 
Theme Examples from participants 
Life before and after knowing HIV 
positive status 
“I was not well generally, but I was not bedridden” (1:4) 
“I was sick, having running stomach [sic]”, getting sick 
now and again (3:298) 
Initiating and continuation of ART 
“They made us to attend classes, took bloods and given 
appointment for follow up, until I was put on treatment by 
that time one is singing the information about medication 
even before you take them [sic]”. (10:1324-1336) 
ART: Adherence to and side effects of 
treatment 
“My CD4 was low so they recommended to start 
antiretrovirals [sic]”(1:26) 
“You are taught about different ARVS with your 
supporter” (3:376) 
 “I used alarm in my phone [sic], to remind me to take 
them at 8am and 8pm, at 7.30 I make porridge and take 
them [sic] at 8am, and my supporter reminds me in the 
morning  and evening” (3:378-380) 
“I used to feel dizzy, I think Stocrin caused it even if I was 
sleeping but it was for a  short time and then it was over” 
(3:383-384) 
“So I developed rash [sic], and sometimes I was weak, 
there is one tablet I take in the evening which made me 
feel dizzy, once I had taken it, I was forced to go to sleep” 
(5:541-543) 
Social support for people on treatment “The only person who knows is my daughter who will 
disclose to my parents when my last days come, because 
she’s my blood she’s with me through all hardships” 
(9:1222-1225)  
“I think  home is an important support system [sic], 
people who are close to you, someone or all need to 
know at home so that they remind you” (3:388-389) 
 
Positive outcomes of being on ARV 
treatment 
“So I got used to treatment and things  
got better and I was right [healthy], my weight improved 
because I lost weight until I weighed 69kg, it improved to 
80,4kg. So this year I’ve started my studies  with UNISA 
[the University of South Africa]…”(5:545-547) 
 
Improving access to ARV treatment 
services 
“I spend R24-00 return trip coming to the clinic” (11:1515) 
“My home is far, I stay in my workplace, 
 I’m a domestic worker my employer 
 brought me here, my home is 
at Ndwedwe…”(5:685-689) 
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4.3.2.1 Life before and after knowing HIV positive status 
This theme describes the experiences as shared by interview-participants before finding out 
their HIV positive status; what motivated them to get tested for HIV/AIDS; and what it was 
like living with an HIV positive status. Most participants highlighted that before knowing their 
HIV positive status they were suffering from multiple illnesses. They had repeated bouts of 
sickness, although they were not bedridden: 
 “I was not well generally but I was not bedridden…” (1:4) 
 “I was sick having running stomach getting sick now and again...” (3:298) 
 
TB was reported as a common opportunistic infection by the majority of participants: one 
participant mentioned that she was coughing a lot in the evenings and was tested to 
exclude TB at the clinic. Most interviewees had already been on a TB regimen by the time 
they were started on ART: 
 “It was discovered that I have TB of glands [sic]… I was put on TB treatment; I took it 
until I finished treatment...” (1:6&10). 
 “They discovered also that I have TB...” (7:828).  
 “I started treatment in December 2007, I was told to start with TB treatment first for a 
month then take ARVs [sic], I think I started ARVs in January 2008 even now I’m taking 
them [TB drugs] because I was told to take them for nine months...” (7:890-893). 
 “I developed TB as well, I treated TB this side and ‘this condition’ this side, they gave 
me TB treatment for two weeks then I started ARVs [sic]...” (8:1060-1062). 
 “They told me to start TB  treatment , I think I was not yet seriously ill except for chest 
problem , I took TB treatment for six months and finished them, by then I was not at the  
stage of starting ARVs I was found to have TB [sic]...” (9:1165-1166). 
 “I was coughing a lot in the evenings and afternoons, I decided to check TB and I 
discovered I had TB...” (11:1397-1398). 
 “I was right [healthy] the only problem I had was difficulty in breathing, loss of weight, as 
from 2003 I was ok [healthy] weighing 48-50kg, it’s TB that gave me problems...” 
(12:1534-1535). 
 
For many interviewees the process of HIV testing and accessing ART occurred in a context 
of multiple stresses, such as illnesses or the death of a family member. One participant 
sought HIV testing because she was pregnant and was enrolled in the PMTCT programme: 
 “I was right [healthy] I didn’t have any problems, then in 2003 I fell pregnant and I was 
tested for HIV and found to be positive”(12:1524.) 
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Most participants indicated that relatives and frequent illnesses were the motivating factors 
to test for HIV. Discovering the positive status raised a variety of emotional reactions to 
participants including crying, being ignorant, difficult feelings, spending sleepless nights and 
thinking endlessly. However, for some, discovering the status brought relief: 
 “I accepted and I got relieved [sic] and I wished I could start treatment… maybe it’s 
because when I was sick I was suspecting [sic] that I may be infected” (3:360) 
 
Most participants shared that when living with HIV they were using Zulu medicines from 
traditional healers. Some mentioned that they were scared of ARVs, although the 
counselling that they received in the clinics after testing positive included literacy sessions 
on ARVs, most still preferred traditional remedies in the form of ‘Imbiza’ (herbal medicine) 
to ART: 
 “I was using Zulu herbs, scared to take pills for life” (7:842). 
 “I was just using Zulu medicines, enema [sic], steaming everything...” (10:1304). 
 
Most participants started by shopping around for other locally available remedies in an 
effort to manage the condition themselves; the cost involved was also shared by some 
participants since affordability was a problem for some:  
 “I used to go and search for imbiza [herbal medicine] with red ribbon sign [sic] and 
when checking the price …R150-00 / R100-00 hmm no, for life [sic]! I thought I was not 
going to afford [sic]” (11:1456-1457). 
 
It was interesting to note that when people were diagnosed as HIV-positive, their first point 
of contact to seek assistance was the traditional healer or herbalist. These therapists 
provide treatment in the form of inducing vomiting (ukuphalaza), an enema (ukuchatha) or 
steaming (ukugquma). It was only after these efforts had failed that participants sought 
medical assistance by approaching the nearby clinics. 
 
4.3.2.2 Initiation and continuation of ART 
This theme highlights experiences shared by participants by relating to procedures they 
went through, from testing for HIV up to starting ART. The route followed by clients, from 
deciding to be tested for HIV through to being enrolled to a lifetime ART programme, is a 
long one, and requires commitment and strong will power to be able to face the challenges.  
 “She told me about HIV, that when results are positive or negative, it does not mean 
that you are going to die…but when I need assistance and when I’m in a stage for 
getting ARVs, they offer assistance [sic]. She told me that after doing a test I’ll need to 
do CD4 test as well [sic]” (1:16-18). 
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 “I came to meet the dietician, I was told to go for classes …We were taught about 
ARVs, we were taught about all types of ARVs” (4:491) 
 “Doctor started me on treatment, CD4 was 74 [sic], my mom was my supporter” 
(8:1058) 
 
One participant was not satisfied with the waiting list clients are put on before being initiated 
on ART, especially when the individuals have low CD4 counts.  This participant felt that 
certain clients need to be prioritized and be initiated on treatment sooner.  
 “The way I was sick [sic]… some people were given earlier appointment [sic]... The way 
I was sick I ended up going to a private hospital... thereafter I had no complaints but 
they didn’t prioritize me in spite of reporting that I’m sick [sic]”(8:1119-1121). 
 
4.3.2.3 ART: adherence to and side effects of treatment 
In this theme, the participants’ experiences of taking ART, strategies for adhering to the 
treatment and the side effects of the medication are highlighted. 
 
Participants reported that they had received basic information about the reasons for taking 
ARVs, how they should take the pills, the importance of not missing the doses and the fact 
that ARVs have some side effects. They all reported that before they were put on ART, they 
were made to attend literacy classes.  At the start of ART, interviewees reported that the 
main criterion for enrolment into the ARV programme was to come with a treatment 
supporter (an individual to whom PLWHA had disclosed their status to). Their role was to 
attend the literacy classes with the client they were supporting, as well as offering ongoing 
support and enforce adherence to ART.  
 
Generally, adherence levels to ART were reported to be high for all interviewees; although 
the majority of them had only been on ART for a short period of time, most of them had 
initiated their treatment when they had AIDS-defining illnesses. All participants had a clear 
understanding that ART was life-long therapy, and some even equated this with other types 
of chronic medication. Some participants were concerned about the side effects of 
medication. 
 
Most participants discovered their HIV status when they were already experiencing 
symptoms of AIDS-defining illnesses. They were often initiated on ART as soon as the CD4 
test and safety bloods results were known. Some participants had been advised to 
postpone initiation of treatment until the criterion for starting ARVs was met.  
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 “Doctor started me on treatment; CD4 was 74 [sic]” (8:1056). 
 “It was in 2005 when tested but scared to take lifelong medication [sic], then in 2008 I 
started the medication, my CD4 was found to be low, I said I’m starting medication. I 
told myself I’ll take these pills for the rest of my life…I was told to go for classes, for 
three sessions” (7:848-849). 
 “They checked my CD4 again in July and it was 9… I was then referred here at VCT 
[sic] and I started ARVs” (12:1532.) 
 
Most participants had developed their own methods and reminders for taking medication. 
These included: 
 using a cell phone alarm 
 linking doses with meals 
 always carrying a supply when leaving the house 
 linking doses with their favourite television programmes  
 Filling up prescriptions before running out of ARVs.  
 
Significant others also played an important role in reminding them to take their medication, 
whether or not the relatives knew what they were for. The importance of the correct timing 
of doses was well understood, and the majority of participants were receiving their 
medications twice-daily: 
 “I used alarm in my phone [sic], to remind me to take them at eight in the morning and 
eight in the evening, at seven-thirty I make porridge and take them at eight in the 
morning, and my supporter reminds me in the morning and evening”(3:378-379) 
 “I use my phone alarm, even at home they know that I take them at 9 in the morning 
and 9 in the evening, my phone also reminds me [sic]”(4:495-496). 
 “I decided to discuss this with my daughter…I disclosed to her…So I said ‘Please be my 
time keeper, remind me’” (5:628-645). 
 “I take them regularly, I made this to be part of my life [sic], I know my times, eight-thirty 
in the morning and eight-thirty in the evening, I don’t forget, I haven’t missed them even 
a single day [sic]…If I’m out till late I take the dose with me to make sure I take it at the 
right time” (10:1370-1373). 
 “I chose to take them at nine in the morning and nine in the evening... nine pm is right 
because at eight pm I watch the Generations soapy [sic] and watch the next drama until 
nine pm, then take my pills; after that I go to bed straight and not do anything [sic]” 
(11:1475-1480) 
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Some individuals were also taking other medications, for the treatment of opportunistic 
infections such as TB, in addition to undergoing ART. They reported that combined 
medications caused additional challenges for adherence because of the ensuant “pill 
burden” (number of pills taken by the client).  
 
In the scenario where a client is taking both ARVs and TB treatment, a client may take 
more than ten pills just for a morning dose: the public sector standard treatment regime for 
these combined conditions is five tablets of Rifafour for TB, vitamin B6 (Pyridoxine) as part 
of the vitamin complex needed to prevent occurrence of peripheral neuropathy (South 
African National ART Guidelines, 2004:87), ARVs and other prophylactic therapy to prevent 
Pneumocystis pneumonia (PCP). 
 “I started ARVs, I developed TB as well, I treated TB this side and this condition [being 
HIV positive] this side, they gave me TB treatment  for 2 weeks then I started ARVs” 
(8:1060-1062) 
 “It was discovered that I have TB of glands [sic]…I was put on TB treatment and I took it 
until I finished” (1:6-7) 
 
Most participants reported that it had been explained to them that ART might cause side 
effects, and most reported experiencing side effects including skin rashes, headaches, and 
fatigue and sleeping disturbances during the weeks of initiating ARVs. Very few individuals 
reported not having experienced side effects of the medication, although for some, side 
effects had disappeared completely by the time of the interview. In spite of this, participants 
reported that the benefits of taking ARV medication outweighed the risks and discomfort. 
 “So when I started treatment in 2006, I got sick, treatment made me to be sick [sic]…I 
developed rash [sic] and it made me uncomfortable. Well, I told myself that I’ll get used 
to the pills…so I developed rash [sic], and sometimes I was weak,… there is one tablet 
I take in the evening which made me feel dizzy; once I had taken it, I was forced to go 
to sleep...so I got used to treatment and things got better [sic]”(5:537-543).  
 “Problems started; painful feet, I couldn’t walk at all; my mom did warm compresses 
and they helped me as I was not given any treatment for painful feet…and I developed 
rash in my face [sic] but it subsided again…only the feet that were problematic [sic] my 
head was…. especially the tablet I take at night my head was like dizzy [sic]” (8:1064-
1066). 
 
Participants used a variety of strategies for dealing with side effects, some of which 
included taking pain killers; using topical ointments (for skin rashes); warm compresses; 
and rest and perseverance. 
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Most participants also reported dramatic improvements in health, including weight gain as a 
result of the return of their appetites, and so participants were motivated to sustain ART 
and ensure that they minimized defaulting treatment. Motivation to adhere to treatment was 
high, and centred on personal, social, family and health aims. Many indicated a strong 
desire to survive long enough to ensure care for children and not leave them as orphans. 
 
4.3.2.4 Social support for people on ARV treatment 
This theme describes the support structures available for people on ART and the 
importance of having these when coping with the demands of the ART programme. 
Participants mentioned a variety of support needs, including: 
 emotional support 
 counselling 
 food 
 family support s 
 support from health professionals  
  
Families were placed at the forefront of social, emotional, physical and economic support 
for HIV- and AIDS- related treatment and care.  Relatives are often sources of information 
and encouragement on advising other members to go for HIV testing, including where to go 
and where to access support for HIV- and AIDS- related care and ARVs. 
 “I think the home is an important support system, people who are close to you…(pause) 
you need to disclose to make it easy, even if you forget the pills someone at home will 
remind you by asking if you’ve taken your pills”(1:73-74) 
 “My mother is so supportive…So, that afternoon I showed her results and she was 
supportive…I haven’t been in a difficult situation” (4:454-456) 
 “I knew my status in 2005 and my health status was not good, my sister kept on saying 
I must take ARVs…I asked my sister to come and sleep with me…she kept on 
reminding me not to forget and I told her I’ll never forget”(7:851-856) 
 “My mom was my supporter since I started ARVs” (8:1058) 
 “I have no problems; my daughter supports me and my parents are a warm [sic],  my 
children make sure I take pills at the correct time, they ask me if I’ve taken pills, they 
even pack for me the ones I take when I’m at work [sic]…my daughter is with me 
through all hardships”(9:1238-1240) 
 “I get a huge amount of support from my partner, as she is the one who motivated me 
to get to this programme, she kept on nagging me” (10:1375-1376) 
 
CHWs were also reported as significant people in providing support for PLWHAs. Their 
roles included home visiting for further support regarding adherence to treatment (including 
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treatment for opportunistic infections); assisting with the various difficulties of disclosure; 
and making arrangements for food parcels if necessary. 
 “There are CHWs who do home visits so I called her and told her that I’m positive and 
told her that no one was working at home only granny is at home, so she tried to bring 
me food parcels at home [sic]… I also asked her to tell my granny because she was 
going to be surprised why I was receiving food parcels [sic]” (3:362-367). 
 “My CHW, I have a CHW who helps me since I started TB treatment” (12:1562). 
 “She [the counsellor] used to come and visit me in the ward and invite me to visit, so I 
became free [sic] and got attached to her… she motivated me because I wanted to 
desert even my work [sic], but she encouraged me to continue with my studies” 
(11:1429-1431) 
 
Most interviewees highlighted the support they got from the nurses who were rendering 
treatment, care and support in the ART programme.  
 “Nurses are my friends I don’t have a problem [sic]” (10:1382) 
 “I have no problems, even with my doctor I ask her everything, I believe in voicing 
concerns, I feel warmth from clinic sister [sic], I told myself I won’t have problems when 
the sisters are available to help me”(9:1257-1259) 
 
However, some did report negative attitudes and bad treatment by the nurses. 
 “Sometimes they treat you badly, as if your mind is not functioning! So [sic] if she treats 
me badly it will be difficult for me to come back and share my problems with her next 
time…so [sic] if they [the nurses] can be open that will make easy for us [the clients] to 
be open as well…some will treat you as if you are an idiot!... let’s say they tell you 
something you don’t understand and you ask them to re-explain, some react badly if 
you ask!”(4:500-511) 
 
4.3.2.5 Positive Outcomes of Being on ART 
This theme highlights the participants’ experiences about the outcomes of being on ART.  
Most interviewees shared positive outcomes and experiences while taking ART, including 
an improvement in physical, social and emotional well being, as well as a greater sense of 
optimism about the present and the future. Although some participants raised concerns 
about the possible long-term side effects of medication that could counteract the positive 
outcomes, many participants mentioned that being able to continue to care for their families 
and children was an enormously beneficial outcome of being on ARVs, and interviewees 
praised ART for the positive results they noticed in their health (including weight gain and 
the return of physical strength): 
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 “My weight improved...I lost weight until I weighed 69kg, it improved to 80,4kg [sic]” 
(5:546) 
 “I noticed the difference, started to gain weight and recovered from weakness and 
became normal again. Even people who knew me when I was sick noticed the 
difference” (9:1168-1169) 
 “I feel very well, I’m light [sic], able to work, before my whole body was sore [sic]…I’m 
well, I highly recommend these pills” (7:897-899) 
 
One participant mentioned that ARVs also improved his libido: 
 “The feelings… your body becomes strong again… you seek to have a sexual 
relationship now! I’m right, I feel right truly” (10:1357) 
Another participant reported to have been registered with a university to further her studies 
because she has regained normal life: 
 “So, this year I’ve started my studies with UNISA…” (5:547) 
 
4.3.2.6 Improving access to ARV treatment services 
Interviewees often have to travel considerable distances to access HIV- and AIDS-related 
treatment. This is costly, both in terms of finances and the sometimes considerable waiting 
times for treatment (resulting in abseentism from work). Centralization of ART-initiating 
hospitals contributes to these problems, as ART is not initiated in the primary health care 
clinics (which are more within reach to clients). The average time travelled to the initiating 
hospitals was 30 minutes to one hour with a maximum cost of R24-00 per return trip: 
 “My home is far [sic], I stay in my workplace [sic], I’m a domestic worker, my employer 
brought me here [to the clinic]...” (5:685-689) 
 “I spend R24-00 coming to the clinic and going back home” (11:1515) 
 
4.4 PHASE THREE: THE EXPERIENCES OF HEALTH CARE PROVIDERS WORKING IN 
THE ART PROGRAMME 
 
A total of four health care providers were interviewed on their experiences with rendering 
care to HIV positive clients receiving ART. These interviewees were comprised of both 
professional nurses and counsellors. 
 
The concerns raised by health care providers were related to health service provision and 
the quality of nursing care. Health care providers spoke about the human resources 
constraints that prevail in the public sector. They raised concerns that the health care 
provider/patient ratio was inadequate to deal with ever-increasing patient numbers needing 
ART, and that this had a negative impact on the overall quality of nursing care. Data 
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saturation was reached after interviewing the third health care provider. To confirm this, one 
more health care provider was interviewed. The following themes emerged from the 
interviews: 
 
Table 4.8: Main Themes in the Health Care providers’ Words 
Theme  Examples 
Establishing and maintaining good client-   
provider relationship 
“The difficult time is the first day; you need to 
establish good relationship and make the 
client close to you, don’t scold them, be at 
their level even if they do wrong things don’t 
shout at them [sic]”(2:75-79) 
Facilitators of adherence to treatment 
“Trying by all means to make clients feel at 
home, to make them feel like they are coming 
to their support group if they come to clinic 
[sic]”(1:45-47) 
 
Barriers to access to treatment 
“Sometimes clients when they come here 
they recognize members of staff who are their 
neighbours [sic]”(1:28-30) 
 
4.4.1 Establishing and Maintaining Good Client/Provider Relationships 
Health care providers mentioned that the first day of meeting the client is the crucial one in 
establishing sustainable long-term relationships. They reported that warmly welcoming 
clients during the first encounter puts the clients at ease and goes a long way to allaying 
fears and anxiety. The establishment of a trusting relationship was reported to be enhanced 
by the type of questions that the provider asked the clients, these needing to be as simple 
and non-threatening as possible. Providers also mentioned the importance of non-verbal 
cues, as the clients observe facial expression during communication.  
 
Friendliness that is displayed by facial expression in the form of a smile, and acceptance of 
the clients irrespective of their condition were reported to be the main factors contributing to 
trust and a positive long-term relationship. Providers also highlighted the importance of 
listening to the clients, as they tend to need a lot of attention, especially during the first 
encounter: 
 “I give him a warm welcome and make him feel more welcomed the way you talk with 
him, even when looking at your facial expression, the client must feel at ease to talk to 
you [sic]” (1:3-5) 
 “If they are welcomed well and listened to during first encounter they develop to trust 
you and develop that long term relationship with you, listening to your clients 
establishes relationship [sic]” (1:15-17) 
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 “You need to be friendly, your facial expression when greeting the client for the first 
time,  show the smile, give love , even if she has sores touch her, hug her if there is a 
need because they feel its end of the world and they look at your facial expression as 
you talk to them to watch your reaction , there are those with cancer of cervix, vaginal 
discharge with a smell, but make sure you don’t show them with your expressions and 
by opening windows [sic]”(2:58-65) 
 “The difficult time is the first day  you need to establish good relationship and make the 
client close to you, don’t scold them, be at their level even if they do wrong things don’t 
shout at them [sic]”(2:75-79) 
 
Health care providers reported that the environment where interaction takes place needs to 
be conducive to welcoming the client, and free from interruptions to encourage the client to 
talk openly. Achieving these was reported to be construed by the clients as respectful, and 
in return the clients were more willing to trust the provider: 
 “Even the environment helps; it must be free from interruptions so that the client feels 
easy to talk even private issues, there are things clients would not like to talk about in 
the presence of other people [sic]”(1:10-13) 
 
4.4.2 Facilitators of Adherence to ARV Treatment 
Interviewees reported that creating an enabling environment for clients facilitates 
adherence to ART: 
 “Trying by all means to make clients feel at home, to make them feel like they are 
coming to their support group if they come to clinic [is important]...”(1:45-47) 
 
Interviewees also mentioned that improvements of the patient’s condition manifested in the 
form of general health improvement, including weight gain due to increased appetite and 
reduction/improvement of opportunistic infections, due to the adherence to ART. On-going 
counselling on the importance of adherence to treatment and the ill-effects of defaulting 
treatment were also reported as motivating factors to stick to ART. 
 
4.4.3 Barriers to Access to ARV Treatment 
Nurses and counsellors reported that when clients visit the clinic and discover that there are 
staff members they know they do not feel comfortable, especially since, at this point, most 
of them will not have disclosed their status and that this occurring does lead to non-
adherence.  
 
Denial, in the form of non-acceptance of an HIV-positive status and the sometimes harsh 
treatment by staff members were also reported as barriers to treatment. Health care 
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providers were viewed as being “harsh” by clients if they were scolded for not complying 
with clinic appointments and defaulting on treatment. Interviewees also reported that some 
clients register in the ARV programme for the sake of getting a disability grant and once 
that is approved they disappear and only return when they develop complications.  
 
 “Sometimes clients when they come here they recognize members of staff who are their 
neighbours who may spread the news in the neighbourhood that he attends ARV clinic 
and they don’t feel at ease to come and they end up defaulting. We’ve seen this when 
we were implementing the down referral programme and when we transferred clients to 
their nearby clinics, clients resist to go there and they prefer to attend the service where 
they are not known even if they can spend a lot of money [sic]” (1:28-37) 
 “Sometimes clients default treatment and when being scolded by sisters, clients label 
that sister as "harsh" and they avoid her, but our staff are very friendly to patients, it’s 
very rare to get such instances [sic]”(1:50-53) 
 “Clients come to the clinic for the sake of getting pension [disability grant], some people 
come to start treatment, comes regularly for three months keeping appointments well, 
then assisted to apply for a grant then disappear, so they come for the sake of pension 
especially those who are unemployed [sic]“(2:99-103). 
 
4.5 CONCLUSION 
There was agreement between the first two phases of the study regarding ART being seen 
as life-saving medication by the clients.  
 
Phase one revealed evidence from literature of the beliefs PLWHA had about ART, and this 
evidence was substantiated by the voices of participants during phase two of the study, 
when clients shared their experiences of undergoing ART.  
 
While health providers confirmed the effectiveness of these drugs marked by general 
improvement of the clients’ condition, they also mentioned that the human resource 
constraints in public health institutions undermine the ART programme.  
 
In chapter five the recommendations, conclusions and limitations of the study are 
discussed. 
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CHAPTER 5 
5. DISCUSSION, CONCLUSIONS AND RECOMMENDATIONS 
 
5.1 INTRODUCTION 
The purpose of the study was to explore the practice of the ART programme regarding 
patient issues and experiences, as well as the experiences of the health care providers 
rendering ART services in three selected ARV clinics, and to develop a guideline for ARV 
services in the eThekwini district. Qualitative research methods were used to conduct the 
study.  
 
During phase one, a metasynthesis of qualitative research studies on HIV-positive patients 
was done. During phases two and three, a phenomenological research approach was used 
to describe the experiences of HIV and AIDS patients as they were lived by the study 
participants in the ART programme. This chapter discusses the findings, conclusions and 
recommendations for each phase of the study, as well as the limitations of the study. 
 
5.2  DISCUSSION ON METASYNTHESIS OF QUALITATIVE RESEARCH STUDIES ON HIV-
POSITIVE PATIENTS ON ART 
 
The metasynthesis revealed a shared set of four themes that increased the understanding 
of the experiences of PLWHA:  
1. acceptance of, and coping with, HIV positive status 
2. social support and disclosure 
3. experiences/beliefs about HIV medication  
4. health care provider relationship/health system factors 
 
Studies reported that accepting and coping with a positive HIV status was difficult. This is in 
agreement with the view of Metcalfe et al. (1998:32) that at initial diagnosis shock was the 
first reaction felt by HIV-infected clients. The importance of people who are HIV positive 
admitting that they have the disease so that they can move forward with their lives is 
highlighted. One informant, as reported by Mabunda (2004:302), said “Denying HIV testing 
is denying life”, as she believed that people must expose themselves to testing, know and 
accept their status and can then begin to protect self and others. Rajabiun et al. (2007:23-
24) confirm that the ability to cope with a positive HIV status is influenced by the level of 
acceptance of a positive HIV status. 
 
65 
 
 
 
The role of social support and disclosure for PLWHA has been emphasized in most studies. 
Friends, partners and family have been highlighted as the most important support systems, 
and Marcenko et al. (1999:40), in their study on “Living with HIV: the Voices of HIV Positive 
Mothers”, agree that the amount of support available for women to cope with their status 
was directly correlated to their level of comfort in sharing the diagnosis. However, there is 
evidence in the literature that clients still hide their HIV positive status from family, friends 
and partners, due to the fear of discrimination and isolation (Golin et al.2002). This poses 
an approach-avoidance conflict for PLWHAs, as they need support from significant others, 
and yet fear rejection and stigmatization due to disclosure. 
 
Studies by Golin et al. (2002:324) and Sidat et al. (2007: 512) reported patients’ 
perceptions about ART that the treatment is life saving yet stigmatizing. There is also 
agreement across studies that PLWHAs taking ART report side effects of the medication; 
however, it is mentioned that they do believe the benefits outweigh the risks, and that this is 
a motivating factor to adherence. 
 
The study by Rajabiun et al. (2007: S-24) mentions that strong, healthy positive 
relationships with health care providers facilitates continuity with medical care, and vice 
versa. However, a non-caring attitude and a lack of respect amongst health providers is 
equally powerful: “They degrade us and shame us, they make us feel bad” (Kumarasamy, 
et al. 2005:531) 
 
5.2.1 Conclusions of Phase One 
This metasynthesis provides health care providers working with HIV infected patients with a 
broader understanding of the feelings, needs, concerns and problems of PLWHAs. For 
example, in all studies the patients’ need for social support and the concurrent reluctance to 
share diagnoses with relatives, friends and/or partners for fears of stigmatization, 
discrimination and isolation were reported. It is therefore recommended that ongoing 
community education continues in order to raise awareness of the disease in the form of 
Information, Education and Communication (IEC) messages (like leaflets and posters 
written in local languages); mass media campaigns; and individual education to eradicate 
the stigma attached to HIV infection.  
 
Because of this enormous need for strong support systems for PLWHA, it is recommended 
that systems be established within the facilities that render comprehensive care 
management and treatment of PLWHAs, including ART. Counsellors trained on the ART 
programme could facilitate the establishment of support groups for people taking ART as 
their chronic medication. Liaison with community-based structures also needs to be 
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enforced; there are already CHWs who are based in the community and conduct daily 
home visits, do community outreach programmes and play an important role in improving 
people’ knowledge about HIV care and treatment, helping them to build skills to incorporate 
HIV into their daily routine, as well as providing a support network. CHOs can provide 
ongoing support, and serve as a link between the health facilities and the clients in the 
community to ensure continuity of care. Health care workers can also help clients to 
establish a network of support services in the community. 
 
Clients perceive ART as life-saving and health care providers need to strengthen and 
sustain this positive view. This can be achieved by having sessions with clients registered 
on the ARV programme which highlight the benefits of the medication by emphasizing the 
fact that the benefits outweigh the risks.  
 
Health care providers need to maintain a stable relationship with their clients, one which is 
non-judgemental and free from prejudice. The importance of displaying warm and caring 
attitudes at all times when interacting with clients cannot be over-emphasized; HIV and 
AIDS is a sensitive subject that needs to be handled with sensitivity and care. 
 
This metasynthesis does have several limitations however, one being that qualitative 
studies that were located and included in the analysis do not represent all possible 
responses to experiences of living with HIV infection.  
 
5.3 DISCUSSION ON THE EXPERIENCES OF CLIENTS ON ART 
In this phase, the experiences of clients on ART; the constraints they are faced with while 
receiving treatment; and the issues around adherence to ARV therapy were explored. This 
phase provides a rich description of the phenomenon of clients’ experiences while receiving 
ART in public health clinics. Six themes emerged from this phase of the study: 
1. Life before and after knowing HIV status  
2. Initiating and continuing ART 
3. Adherence to and side effects of ARVs  
4. Social support for people on treatment 
5. Positive outcomes of being on ART  
6. Improving access to ART services. 
 
In this study there was consensus that people approached health services for voluntary 
counselling and testing only after they started becoming sick. TB had been reported to be 
the commonest infection amongst the immune-compromised individuals who participated in 
the study, and this is consistent with the South African National Guidelines for rolling out 
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ART (2004), which state that TB is the most common cause of death amongst HIV-positive 
people in South Africa. 
 
Another notable finding in the study was the importance of the role that significant others 
play in motivating relatives to go for VCT. This confirms the findings in phase one of the 
study, the metasynthesis, that the friends, partners and family form a major support system 
for PLWHAs. 
 
This study has revealed that PLWHAs accept antiretrovirals as a last intervention, having 
first exhausted the curative properties of herbal remedies in an effort to cure the disease. 
The perception that the side-effects of ARVs can cause long-lasting damage also 
contributed to the postponement of initiating ART.    
 
The long waiting-lists for ART also remain a barrier to access. One participant verbalized 
his dissatisfaction with the waiting period from the time he got his CD4 test results to the 
time of starting ART; he further expressed that clients need to be prioritized according to 
their CD4 test results, to ensure timely access to therapy -this attitude is explained by the 
fact that clients regard antiretrovirals as life-saving medication (Sidat et al, 2007:512). 
 
Another notable finding in this study was that PLWHAs who meet the criteria for starting 
ART were taken through literacy classes with their “treatment buddies”, where positive-
living and adherence to treatment was emphasized. This finding is in line with the South 
African National ART Guidelines (2004). The National Guidelines for Initiation of ART in 
South Africa recommend that a person must disclose to at least one person who is either a 
friend or a relative before initiating therapy, for support and adherence purposes.  
 
ART has brought hope to PLWHAs, and plays a huge role in improving their quality of life. 
However, the effectiveness of this therapy is directly related to the level of adherence and 
commitment to them. Researchers have demonstrated that there are many factors that play 
an important role in adopting and maintaining adherence behaviour. 
 
The parent-child role is reversed as it relates to HIV and AIDS medication adherence for 
the participants in this study, and the fact that children are an important source of social 
support cannot be overlooked. Findings from the current study indicate that children play an 
active role in reminding and encouraging their mothers to take their medications on a daily 
basis, as well as being an important source of comfort. Similarly, clients mentioned the role 
played by other individuals, like sisters, or partners, in providing support to adhere to the 
programme.  
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In keeping with the findings of other studies, the study participants reported a 100% 
adherence to HAART. This resulted from a combination of the following issues:  
 trust in the effectiveness of HAART 
 readiness to go on HAART 
 optimal integration of HAART regimens into individual lifestyles 
 incorporating the taking of HAART medication into a routine 
 planning ahead for events that disrupt daily routines, in order to avoid missing or 
forgetting pills 
 the use of personalized tools and reminders for HAART pill-taking times 
 
HAART is viewed as a lifeline, and so it becomes an integral part of the lives of PLWHA; 
the continuous development and increasing availability of new HAART regimens also 
engenders optimism and a positive future outlook. These findings are consistent with the 
findings of other studies on HAART adherence. (Sidat et al, 2007:512-514).   
 
Although families have been placed at the forefront of the primary social, emotional, 
physical and economic support for PLWHA, all participants but one reported having 
excellent relationships with, and feeling well supported by, their health care providers, 
including counsellors.  Community-based resources like CHW were also reported in this 
study as playing a significant role in providing support to PLWHA. 
  
The study participants felt very optimistic about their future outlook with HAART; they 
referred to HAART as responsible for the improvements they observed in their health and 
well-being, as well as in their biological parameters (weight and CD4 counts).  
 
The study findings revealed problems related to accessibility of ARV services, since the 
majority of clients incurred the travelling costs to the initiating sites. This situation is then 
worsened by long waiting periods for the service to be rendered, which has effects on 
absenteeism at work. 
 
5.3.1 Conclusions of Phase Two 
Conclusions from the first theme, “Life before and after knowing HIV status”, indicates that 
people usually manifest symptoms of opportunistic infections before they become aware of 
their HIV status. TB was reported by most clients as the primary infection, since the 
majority of them were diagnosed with TB and were taking treatment for it before they 
become aware of their HIV positive status. TB is a huge public health problem, and is the 
leading cause of death amongst HIV-positive South Africans. Efforts towards strengthening 
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existing TB control programmes and combating the high default rate need to be applauded, 
but contact tracing and prophylactic treatment still need to be strengthened. 
 
Conclusions can also be made that clients seek assistance from traditional healers before 
visiting health centres. 
 
The conclusion drawn from the second theme, “Initiating and continuing antiretroviral 
therapy”, was that the turnaround time from testing for HIV to initiation of ART was very 
long, and the lack of prioritization of critically ill people was specifically mentioned by one 
participant. 
 
In making conclusions based on the third and fourth themes, “ART, adherence and side 
effects” and “Social support for people on treatment”, it was clear that people do not 
voluntarily approach health services to seek HIV testing services unless there are strong 
compelling factors. The discussion with HIV-positive participants clearly revealed that 
frequent illnesses were the most compelling factors to test for HIV, but that relatives were 
also important motivators for HIV testing when these illnesses occurred. The role of 
significant others in providing support for PLWHAs cannot be over-emphasized, while other 
community-based structures, including CHW, also play a significant role. General 
improvement of well-being was repeatedly mentioned as the motivating factor in HAART 
adherence. 
 
All the participants confirmed that people who had experienced advanced AIDS disease-
symptoms tend to adhere more to treatment than those who had never experienced such 
symptoms.  This finding confirms the researcher’s practical experience whilst giving 
technical support in the ARV initiation sites when the ARV programme was still in its infancy 
stage. Clients never missed their appointment dates for examination by the doctor, and 
always arrived to collect their medication. Clients also displayed commitment to attending 
the literacy sessions accompanied by their treatment supporters, who played a further role 
in therapy by reminding the clients to take their medicine at the proper times. 
 
Clients testified to the positive results of being on treatment (theme five, “Positive outcomes 
of being on ART”); as these effects enabled them resume their roles as providers for their 
families. General health improvement and the regaining of physical strength were amongst 
the benefits highlighted.  
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Issues of access still need to be addressed. This phase of the study indicates that the ARV 
services remain inaccessible to some clients, as long-distances travel is required to access 
them and this has an element of cost involved. The long waiting-times for treatment are 
also included under issues of access.  
 
5.4 DISCUSSION ON THE EXPERIENCES OF HEALTH CARE PROVIDERS WORKING IN 
THE ART PROGRAMME 
 
This phase of the study discusses the experiences of health care providers rendering ART 
services to PLWHA enrolled in the ARV programme in the public health sector clinics.  
 
There was an agreement amongst health care providers that clients’ relationships with their 
health care providers were critical in clinical management of HIV infected individuals. A 
good provider/patient relationship was mentioned as a motivating factor in maintaining 
clients’ commitment to ART, including treatment for opportunistic infections. The 
establishment of a good rapport from the first meeting was emphasized in the 
establishment of positive long-term relationships. 
 
Providers also highlighted the importance of being aware of their non-verbal cues, as these 
may send negative messages to clients. The importance of displaying a caring and non-
threatening attitude with respect for clients was repeatedly emphasised by providers. 
Vervoort et al. (2007:278) states that “having faith in the health care provider, and the 
experience of a good relationship with the health care provider that is based on trust and 
professional support, seem to influence adherence positively. Characteristics of a 
supportive health care provider include a caring attitude, effective and frank communication 
and clear instructions, being responsive and accessible and showing respect”. Therefore 
the attitude displayed by health care providers in the daily management of patients is 
crucial in promoting service-utilisation by clients. Customer service is not a department, it is 
an attitude.  
 
One notable finding reported by the clients was that the general improvement of client’s 
condition, combined with ongoing counselling and educating clients about the negative 
effects of failing to stick to treatment were important in keeping appointments to come to 
the clinic.  
 
Fears of being identified by neighbours or staff members known to them through 
community ties, is a problem faced by PLWHA, as that would mean behavioural disclosure. 
Clients preferred visiting clinics far from their neighbourhoods to avoid this, and this 
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response had a cost element involved. Disclosure and stigma were therefore main factors 
contributing to the poor access of treatment by clients.  
 
These findings are in line with the findings from other studies. Golin et al. (2002:322) 
indicates that “participants were afraid that taking antiretroviral medication would reveal 
their HIV serostatus to others and many perceived a severe social stigma associated with 
being known to be HIV positive. The fear of being identified as HIV positive lead many to 
miss antiretroviral doses”.  This concurred with the responses from health care providers, 
as they stated that when clients visited the clinic where they were known by a staff 
member, they seemed uncomfortable and would then default on any future appointments. 
 
Health care providers also mentioned that occasionally clients seek ARV clinic services for 
the sake of accessing the disability grant. They explained that clients become compliant for 
the first three months while their application for the grant is being processed and thereafter 
disappear. This behaviour has a negative effect on adherence to therapy as clients need to 
take treatment for the rest of their lives to prevent development of drug resistance. Non 
adherence to antiretroviral therapy is a public health problem because individuals who 
default treatment will be spreading resistant HIV strains to members of the public should 
they practice unprotected sex. 
 
Health care providers reported that they also need ongoing training on HIV- and AIDS- 
related care to prepare them to face daily challenges in the management of HIV infected 
individuals. 
 
5.4.1 Conclusions of Phase Three 
The health care provider has a fundamental role as either facilitator or barrier in the process 
of clinical HIV and AIDS management for PLWHAs. Health care providers in this study 
emphasized the importance of caring, respect, good communication and proper skills to 
render the service. Similarly, participants had closely observed their providers’ actions, 
words and body language and they valued the providers’ time and attention. 
  
Health care providers serve as the initial points of contact in a health facility and therefore 
they need to be welcoming to clients at all times in order to establish and maintain good 
relationships. They also need to have good skills in customer-care, as, ultimately, clients 
approaching health centres are customers, and consumers of a service. A long-lasting, 
trusting relationship is built upon the first contact with the client, and health care providers 
working in the ARV clinics need to be sensitive and show respect to clients at all times due 
to the sensitive nature of the subject.  
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Health care providers need to observe the ethical principles of justice, beneficence and 
privacy in order to maintain sustainable provider/client relationships. Health care providers 
need to be conscious of the fact that creating a therapeutic environment for clients that is 
non-threatening and non–intimidating can facilitate adherence to ART. Displaying 
knowledge about the disease, providing information and the ability to answer questions 
correctly about the subject at all times can assist clients to adhere to their medication. Good 
communication skills and a gentle manner when addressing clients contribute to treatment 
access. Health care providers need to realize that a breakdown in communication serves 
as a barrier to accessing services. 
 
5.5 RECOMMENDATIONS 
The following are the recommendations made based on the lessons learnt from different 
phases of the study: 
 
The path from HIV testing to initiating treatment and ongoing care and support needs to be 
a seamless path with no barriers to access of the service. 
 
PLWHAs have problems in accepting and coping with the disease. Efforts must be directed 
at combating the stigma attached to HIV infection by empowering communities with 
knowledge. Communities need to change their mindset about HIV infection and realize that 
HIV and AIDS is a chronic disease and can be prevented and managed like other chronic 
conditions. The South African government is making efforts towards destigmatizing HIV and 
AIDS by implementing the upward and downward referral programme. The ARV initiating 
clinics within the hospitals and CHCs commence treatment, and thereafter refer clients to 
their local clinics for continuity of care. The clinics can refer them back to the initiating sites 
should they experience severe side effects or if complications arise. 
 
PLWHA must be reassured that being infected with HIV is not a sin, and therefore feelings 
of guilt are misguided reactions. The multidisciplinary team approach towards 
comprehensive management of HIV and AIDS must be strengthened. Psychologists, as 
members of the team where available, must provide ongoing counselling to assist PLWHAs 
in gain accepting and coping with the disease and therefore reducing stress levels and fear. 
In the sites where there is lack of psychologists, professional nurses registered as 
psychiatric nurses and even trained counsellors must render these services to ensure 
comprehensive management of PLWHAs.  It is also recommended that chaplains be 
members of the multidisciplinary team to address the spiritual needs of HIV infected 
individuals as it documented that spirituality, prayer, faith, “inner strength” and even positive 
thinking help to develop feelings of self worth and gain acceptance of the disease. 
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The need for support groups for PLWHAs cannot be over-emphasized, and the role of 
support groups becomes evident when HIV infected individuals become comfortable to 
disclose their HIV status. Significant others, including family members, friends and partners, 
are vital in providing social support and thereby facilitating disclosure. 
 
Health care providers must strengthen education on the mode of action of drug regimens, 
the possible side-effects of the medicine, and the importance of adherence to medication, 
and so dispel the myths and misconceptions surrounding antiretrovirals. Health care 
providers must also assist PLWHAs on treatment to fit the treatment regimens into their 
lifestyles in order to achieve maximum benefits of treatment. 
 
Health care providers must display professionalism at all times when caring for patients. 
They must be supportive, respectful, non-judgemental, and always show sensitivity when 
working with HIV infected individuals. Health care providers must always strive for a long- 
lasting relationship rooted on a foundation of trust with their clients.  Health care providers 
can be either facilitators or barriers in terms of ART access. 
 
Study participants mentioned that they were suffering from multiple illnesses before they 
became aware of their HIV status, with most of them already taking treatment for TB. It is 
recommended that members of the public be encouraged to test for HIV and know their 
status regardless of their seeming wellbeing, as this will assist with both early identification 
and the management of opportunistic infections caused by a deteriorating immune system 
they’ll be registered on the comprehensive HIV and AIDS management programme and 
being monitored on an on-going basis.  
 
Education needs to focus on motivating members of the public to seek assistance early 
from health centres. Most participants shared that they started by shopping around for 
locally available remedies in an attempt to manage the condition on their own.  Foregoing 
this route and approaching health services early on will ensure maximum benefits for their 
health, as infections will be managed before complications arise. The South African 
government launched the HIV Counselling and Testing (HCT) campaign on the 1st of April 
2010 in an attempt to mobilise all South Africans to get tested for HIV and know their 
status. HCT is offered by health providers on the occasion of any patient’s visit to any 
health facility for any ailment. HCT is considered to be the entry point to HIV prevention: 
knowing one’s status and knowing what to do next, and so facilitating access to ART. 
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In this study, although high adherence levels were reported by the study participants, it is 
still recommended that the public health sector trains more counsellors on adherence 
counselling. The success of the ART programme is totally dependent on adherence. 
People taking antiretrovirals need to achieve <95% adherence to treatment, and failure to 
do so may lead to emergence of drug resistant HIV strains -hence the need to strengthen 
adherence counselling. There is also a need to improve the turnaround time for initiating 
treatment and waiting times in the clinic, in order to improve the accessibility of ART 
service. The human resource constraint remains a challenge in the public health sector, 
and this also needs to be addressed for effective service delivery. 
 
5.6  SUPPORT GUIDELINE FOR ART SERVICES IN ETHEKWINI DISTRICT 
This is a description of the daily processes followed in the ARV clinic whenever a client 
walks in for HAART initiation: 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 5.1: Process Map of a Patient Referred for Initiation of HAART 
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5.6.1 Explanatory Notes for the Process Map 
5.6.1.1 Registration 
A patient is entered into a register for statistics purposes. Vital signs are also done at this 
point (temperature, blood pressure and weight measurements). 
 
5.6.1.2 Patient Triage 
The patient is triaged by staff either to the blood room (if he/she has never had a CD4 
done), or if he/she was referred with his CD4 test results from a local clinic, he/she will then 
be sent for literacy sessions with the lay counsellor. He/she will also see the dietician, and, 
if there is a need, he may be referred to a social worker. 
 
5.6.1.3 Routine safety bloods 
Routine bloods for preparation of HAART initiation are done:  
 Liver Function tests (LFT) 
 Urea and Electrolytes (U&E) 
 Full Blood Count (FBC) 
 Wasserman’ Reaction (WR)  
 HBV. 
 
A Viral Load (VL) test is no longer a requirement before initiation of HAART. 
 
5.6.1.4 Screening for Pulmonary Tuberculosis (PTB) and Pap smear 
If the patient was not screened for PTB and or given a Pap smear at the local clinic, this is 
done at the ARV clinic. 
 
5.6.1.5 Literacy and adherence sessions 
These are initiated at the local clinic. Further sessions are done by both the counsellor and 
the pharmacist to discuss treatment options and a treatment plan. 
 
5.6.1.6 HAART initiation 
The patient is seen by the doctor for initiation of antiretroviral therapy. 
 
5.6.1.7 Follow-up appointment and medicine collection 
The patient is given a date for a follow-up appointment and sent to pharmacy to collect 
medication. 
 
It is important to note that the above process can range from one week to one month before 
the patient is initiated on HAART.  
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5.7 GUIDELINES TO IMPROVING ACCESSIBILITY TO ARV SERVICES 
Urgent training of health care providers on comprehensive HIV and AIDS management is 
needed, and this needs to be done both at the initiation sites (which are usually within the 
hospitals), and at a clinic level.  All PHC nurses should be able to provide Provider Initiated 
Counselling and Testing (PICT) at every opportunity. This would increase VCT uptake. 
 
Once the patient has tested positive on a CD4 test, literacy sessions should be started 
immediately and the patient should be screened for opportunistic infections like TB, as well 
as a pap smear for female patients. This would then decrease the screening being done at 
the ARV clinic, and so shorten the time for initiation of HAART. 
 
Early identification and referral of patients for HAART initiation should be done as soon as 
possible. If training is provided at a PHC level and PHC nurses gain confidence in the 
process of initiation of HAART, ideally patients could start treatment at a clinic level, 
meaning treating HIV and AIDS as a chronic condition. 
 
Good systems and adequately trained and knowledgeable health providers should be in 
place in order for the process to run smoothly. Less preparation could be done at the ARV 
clinic if the patients were properly prepared or screened at the PHC level. CD4 staging at a 
PHC level is also crucial to enhance HAART initiation. 
 
5.8 LIMITATIONS 
The limitations of this study were conditions inherent in qualitative research studies: 
 Open-ended questions give much discretion to researchers and respondents 
 The conversational tone has the potential to prompt particular responses or 
inadvertently direct answers 
 The unconscious process is difficult to avoid even with experienced researchers. 
Participants might be reluctant or afraid to tell researcher their views or they may wish 
to promote a particular view of their experience, or may tell only what is in their interest 
 The active presence of the researcher can potentially influence the behaviour and 
responses of participants, thereby compromising research findings 
 
5.9 CONCLUSION 
This study investigated the experiences of clients receiving ART services, and the health 
care providers rendering these services in the eThekwini district, KZN. The study aimed to 
explore the practice of ART specifically regarding patient issues and experiences, as well 
as those of health care providers.  
 
77 
 
 
 
In this study the literature on previous qualitative research done on HIV and AIDS including 
ART was reviewed. This formed the metasynthesis phase, which came up with new body of 
knowledge from previous studies. The metasynthesis revealed four themes:  
1. acceptance of and coping with HIV positive status 
2. social support and disclosure 
3. experiences of and beliefs about HIV medication  
4. client/provider relationships/health systems factors 
 
In this study in-depth interviews were done with participants receiving ART in the selected 
clinics in the eThekwini district. This phase of the study generated six themes namely: 
1.  initiating and continuing antiretroviral therapy 
2. life before and after knowing HIV status 
3. adherence to and side effects of ART 
4. social support for people on treatment 
5. positive outcomes of being on antiretroviral treatment  
6. improving access to antiretroviral treatment services 
 
The last phase of the study consisted of conducting interviews with the health care 
providers providing comprehensive HIV and AIDS treatment, care and support services. 
Health care providers shared their experiences of working with HIV infected individuals 
including those taking ART. The following issues unfolded during the interviews and 
repeated themselves 
 establishing and maintaining good client/provider relationships 
 facilitators of adherence to treatment  
 barriers to access to treatment  
 
This study attempted to answer two research questions:  
1. What are the problems and experiences of patients and health care providers regarding 
ART? 
2. What are the best practices for rendering ART in KwaZulu Natal? 
 
Both questions were answered at different phases of the study. Question one was 
answered during the discussion of phases two and three of the study. The discussion of the 
findings of the study during phase two gives a detailed description of the problems and 
lived experiences of PLWHA and taking ART medication. During phase two clients shared 
their journey from before they discovered their HIV status, as well as living with HIV before 
initiating treatment and the experiences and problems they had when they were eventually 
put on ART.  
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The experiences of health care providers are shared in the discussion of phase three of the 
study. 
 
After repeated interviews with clients and the health care providers who were participants in 
this study, the researcher took a closer look at the current practice in the ARV clinics in 
which the study took place. The process map was drawn, highlighting all the important 
steps that need to be taken into consideration before the client is initiated on HAART. The 
processes were unique to each clinic, as not all clinics provided screening for opportunistic 
infections and pap smears for female clients, and the lack of these services prolonged the 
turnaround time for HAART initiation.  
 
The support guideline was developed to improve accessibility of the service and to address 
some bottleneck issues to ensure that the ARV services are user-friendly. This will also 
enhance standardisation of the service across all clinics, providing comprehensive 
management of HIV in eThekwini district. 
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INFORMATION SHEET FOR CLIENTS 
 
Dear Participant 
I would like to invite you to participate in my research study. The study is on the Experiences of 
Clients on Antiretroviral therapy and their Health care providers in KwaZulu Natal.  The purpose of 
this information sheet is to give you the information you will need to help you decide whether or not 
to be in the study. Please read it carefully. You may ask questions about what we will ask you to 
do, the risks, the benefits, your rights as a participant, or anything else about the research or this 
sheet that is not clear. When all of your questions have been answered, you can decide if you want 
to be in this study or not. This process is called “informed consent”. I will give you a copy of this 
form. 
This study is done to understand the experiences of people living with HIV who are receiving 
antiretroviral treatment, their experiences while taking antiretrovirals and how they adhere to 
treatment.  
Your contribution in this study will benefit others in future by improving antiretroviral services and 
support for people receiving antiretroviral treatment. You will not receive any direct benefit. The 
interview will take from 45minutes to 1 hour.  The interviewer will ask questions and write notes 
about experiences, there are no right or wrong answers to any questions asked during the 
interview. You can refuse to answer questions that you think are private and sensitive.  
Your personal information will be kept strictly confidential, only the interviewer will be present with 
you at the interview. Your name will not be disclosed in any report. The code number for the 
interview will be used for identification purposes so that your real identity and personal details are 
protected and cannot be disclosed to others. Information learned from this study will be used in 
reports, presentations, and publications but you will not be personally identified.  
Participation in this research is voluntary, you may refuse to participate or withdraw from this study 
at any time without coercion. You will not be deprived of any treatment at the clinic should you 
withdraw from the study. 
 
If you have any concerns or problems after the interview contact the researcher at the following 
telephone number: 0833613341 (Mbali), Fax number: 031 7057047 
Have you understood information that has been discussed with you? Yes/No 
Have all your questions been answered? Yes/No 
Do you give your consent to taking part in the interview? Yes / No 
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 Information Sheet for Health Providers 
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INFORMATION SHEET FOR HEALTH PROVIDERS 
 
Dear Participant 
 
I would like to invite you to participate in my research study. The study is on the Experiences of 
Clients on Antiretroviral therapy and their Health care providers in KwaZulu Natal. I’m requesting 
you to share your experiences in working with HIV positive clients receiving antiretroviral therapy. 
This study is done to understand the experiences of people living with HIV who are receiving 
antiretroviral treatment, their experiences while taking antiretrovirals and how they adhere to 
treatment.  
Your contribution in this study will benefit others in future by improving antiretroviral services and 
support for people receiving antiretroviral treatment. You will not receive any direct benefit. The 
interview will take from 45minutes to 1 hour.  The interviewer will ask questions and write notes 
about experiences, there are no right or wrong answers to any questions asked during the 
interview. You can refuse to answer questions that you think are private and sensitive.  
 
Your personal information will be kept strictly confidential, only the interviewer will be present with 
you at the interview. Your name will not be disclosed in any report. The code number for the 
interview will be used for identification purposes so that your real identity and personal details are 
protected and cannot be disclosed to others. Information learned from this study will be used in 
reports, presentations, and publications but you will not be personally identified.  
Participation in this research is voluntary, you may refuse to participate or withdraw from this study 
at any time without coercion.  
For further information please contact Mbali at  0833613341 (Cell number), 031 7057047 ( Fax) 
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 Participant’s Statement of Consent 
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PARTICIPANT’S STATEMENT OF CONSENT 
 
The study has been explained to me. I agree to take part in this research. I have had a chance to 
ask questions. I know that if I have questions about the research or about my rights as a participant 
I can ask one of the researchers at any time. I agree not to disclose to any person outside this 
study any confidential information disclosed to me during the course of this study. I will receive a 
copy of this consent form for my records.  
 
Interviewee code EDP : ____________________________ 
 
Interviewee’s signature : ____________________________ 
 
Interviewer’s signature : ____________________________ Date: __________________ 
 
(This signature certifies that informed consent has been given by the interviewee). 
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 In-depth Interview Guide - Clients 
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IN-DEPTH INTERVIEW GUIDE - CLIENTS 
 
Instructions: The in-depth discussion can only be started after having read the informed consent 
and the respondent has understood and consented to be interviewed. Remember to seek 
permission to use the tape recorder and explain in detail to the respondent before the interview 
begins that the recording is simply made to remind the researcher what was said and its use is 
completely anonymous and confidential.   
 
Date of interview  : ____________________ 
 
Tape record number  : ____________________ 
 
Start time for interview : ____________________ Time interview ended_________ 
 
 
Purpose and process: 
 
The purpose of this interview is to enable the participant to tell his or her “story” about living with 
HIV from the time they were tested through to starting and continuing with antiretrovirals. 
Participants will be asked to tell the story about their experiences, the interview will begin with a 
question: 
 
 “Tell me about your life before finding out about your HIV positive status”  
 
If the discussion ceases, probes such as these will follow: 
 
What led you to do an HIV test? Explain. 
 
Tell me about your experiences when you started ARVs from the time you heard about ARVs until 
you participated in the ARV programme. 
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INTERVIEW GUIDE - HEALTH PROVIDERS 
 
The interview will begin with a question: 
 
“What are your experiences in working with HIV positive people receiving antiretroviral therapy” 
 
If the discussion ceases probes such as these will follow: 
Tell me about how you establish relationship and dialogue with your patients 
What do you think are the barriers to ARV adherence and effectiveness of available services? 
What do you think are the facilitators to ARV adherence and effectiveness of available services 
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ANNEXURE 8 
 Transcript of a Client Interview 
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TRANSCRIPT OF A CLIENT INTERVIEW 
 
Interviewer: Good morning, thank you for allowing me to talk to you. Can you tell me about your life 
before finding out that you are HIV positive?  
 
Participant: About my life 
 
Interviewer: Yes 
 
Participant: Ok, so my life was ok I was right until I got a boyfriend, so I got a boyfriend and we got 
our first baby in 1991 and I didn’t have any problem 
 
Interviewer: In 1991 
 
Participant: Ya, then the second one in 2003, so that’s when I discovered I’m HIV positive with my 
second pregnancy  
 
Interviewer: Ok 
 
Participant: So I was given Nevirapine and the baby was born negative. My CD4 was right at that 
time. So after 2003, 2004, 2005 I started to get sick…2005, that’s when I started taking actions 
though I was not seriously ill.  
 
Interviewer: Hmm 
 
Participant: So I came back to hospital, to test my CD4, by then it was 30 but I was right and 
active… 
 
Interviewer: Hmm 
 
Participant: …I didn’t have problems; I was started on treatment in 2006. So when I started 
treatment in 2006, I got sick, treatment made me to be sick, I developed rash and it made me 
uncomfortable. Well, I told myself that I’ll get used to the pills 
Interviewer: So, can you tell me what problems did treatment give you?  
 
Participant: So I developed rash, and sometimes I was weak, there is one tablet I take in the 
evening which made me feel dizzy, once I had taken it, I was forced to go to sleep. 
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Interviewer: Hmm 
 
Participant: So I got used to treatment and things got better and I was right, my weight improved 
because I lost weight until I weighed 69kg, it improved to 80,4kg. So this year I’ve started my 
studies with UNISA… So I think I’m a bit stressed because I’m losing weight, but I make sure I 
condomise! That’s no joke I’m very strict with that! (LAUGH) 
 
Interviewer: Hmm   
 
Interviewer:  Ok you said you discovered your status when you were pregnant? 
 
Participant: Yes I discovered when I was pregnant 
 
Interviewer: What motivated you to check your status?  
 
Participant: What motivated me to check? 
 
Interviewer: Hmm 
 
Participant: I was motivated to check my HIV status because of my partner’s behaviour. 
 
Interviewer: How was he behaving? 
 
Participant: She was fond of women 
 
Interviewer: Ok 
 
Participant: So I thought I need to protect my baby. At the clinic they educated us on the 
importance of checking one’s status... so I just made a decision to check my status whether I’m 
positive or negative, so that’s when I discovered my status 
 
Interviewer: Hmm 
 
Participant: So I was a bit disturbed initially when I learnt about my status but the way they 
counselled me, I told myself that life will go on. 
 
Interviewer: Ok, tell me more about the counselling you received when testing for HIV. 
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Participant: So I got counselled at Redhill clinic the counsellor told me that being HIV positive does 
not mean that it’s the end of life…. 
 
Interviewer: Hmm 
 
Participant: …So life will go on and I’ll be given Nevirapine as I‘m pregnant to protect the baby. 
She also told me that if I take care of myself I’ll be right! So they counselled me about diet, what 
type of food to eat, the importance of using condoms, and to motivate my partner to test as well. 
You know males don’t easily accept, he said he knows that obviously he is infected. 
 
Interviewer: Hmm 
 
Participant: He told himself that it’s obvious that he is as well infected and didn’t want to test. He 
became sick last year and then started making actions and I helped him to follow the correct 
channels. 
 
Interviewer: Hmm 
 
Participant: So it’s me who was counselling him better, so he also started taking ARVs and he 
became better 
 
Interviewer: Hmm, ok, when you learnt about your HIV status how did you react?  
Participant: I don’t want to lie, I was shocked! I was nearly knocked down by a car on the road 
(LAUGH), it was heavy! It was very very heavy when they told me. So when I got out of the clinic, 
knowing my positive result, I crossed the road and sat down quietly (MUMMBLE) 
 
Interviewer: Hmm 
 
Participant: I didn’t want to take transport home immediately; I wanted to regain my sense of 
thinking well. When recovering from shock I told myself that it’s not the end of life... all you need to 
do is to take care of yourself and the unborn baby, it’s you who’s going to make the baby survive 
and therefore to make yourself survive as well. 
 
Interviewer: Hmm 
 
Participant: So at the clinic they gave me tablets to take for the duration of pregnancy, after 
delivery the baby was given Nevirapine  
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Interviewer: Hmm, so tell me how was it living with HIV, before starting treatment? 
 
Participant: It was difficult, very difficult! It was difficult but I couldn’t wait to start ARVs! 
 
Interviewer: Hmm 
 
Participant: It was difficult, thinking endlessly and I could see I was stressed. Sometimes I used to 
spend sleepless nights thinking but each time I came to the clinic, I was praying that they start me 
on treatment, I mean ARV’s 
 
Interviewer: Why? 
 
Participant: Because I had met other people in the clinic who were on ARVs... because if we meet 
at the clinic we discuss, sometimes a person reads stress in your face and start counselling you 
that you’ll be fine. Sometimes start sharing her story that ‘I was like this and that but I started ARVs 
and became better as you can see me’  
 
Interviewer: Hmm, how do you make sure that you stick to treatment? 
 
Participant: Ok, what helps is that I decided to discuss this with my daughter, so I disclosed to her 
 
Interviewer: How old is she? 
 
Participant: She’s 16years 
 
Interviewer: Ok 
 
Participant: I discussed with her, there was a talk about AIDS on TV… then I just said ‘nana, what 
can you say if I can tell you that your mom is HIV positive’… She just said ‘ma there is no 
difference between 6&9, (LAUGH) what you’ll need to do is to take treatment.   
 
Interviewer: Hmm 
 
Participant: She said ‘ma we are taught about HIV at school so… do you think you have it ma’? I 
said ‘listen my child your mom is positive’ (pause).... she said ‘ma there is no problem’ So I said 
‘Please be my time keeper, remind me, I’ll also try to remember but if you see that I’ve missed the 
time remind me’  
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Interviewer: Hmm, tell me how did you deal with side effects? 
 
Participant: I used to make appointment with my doctor and she gave me treatment … she gave 
me some treatment to apply on the skin...then itchiness became better… 
 
Interviewer: Hmm 
 
Participant: …for dizziness, doctor didn’t give me anything, I make sure that after taking it I go to 
sleep… it helped me, so as time went on I got used to it now it does not affect me, now I take it and 
do not have problems even if I don’t sleep  
 
Interviewer: Hmm, ok, what support do you think people on ARVs need in order to continue taking 
their treatment well?  
 
Participant: To take their treatment well? 
 
Interviewer: Yes 
 
Participant: I think even if people take ARVs, some of them are not well counselled because 
sometimes as we chat to each other you find that some people have stopped taking them because 
of side effects. I thing people need more and more counselling.  
 
Interviewer: Hmm 
 
Participant:  Yes we are taught about ARVs not that they don’t teach us…but you find that some 
people, if taking ARVs and encounter some problems with medication, they desert them… and say 
these pills are problematic, I’m stopping to take them…I won’t continue taking them. I don’t know 
what can be done with this 
 
Interviewer: Hmm 
 
Interviewer: Ok, how old are you?  
 
Participant: I’m 42 years 
 
Interviewer: 42 years, are you married? 
 
Participant: No, it’s on the way 
105 
 
 
 
Interviewer: What’s your religion? 
 
Participant: I worship at Ekuphakameni, at Shembe? 
 
Interviewer: How long does it take you to get to the clinic from    home?  
Participant: My home is far, I stay in my workplace, I’m a domestic worker…I’m using my work 
address, my employer brought me here, my home is at Ndwedwe… but I work in Durban North 
 
Interviewer: Ok, Durban North 
 
Participant: It is not far 
 
Interviewer: Do you have any questions to ask? 
 
Participant: No, because I think I’m losing weight because of stress related to studies 
 
Interviewer: Hmm how was the interview? 
 
Participant: It was right, I enjoyed it. 
 
Interviewer: Thank you 
 
Participant: I liked your questions 
 
Interviewer: Thank you sisi for your participation 
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ANNEXURE 9 
 Transcript of a Health Care Provider Interview 
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TRANSCRIPT OF A HEALTH CARE PROVIDER INTERVIEW 
 
Interviewer: Tell me how do you establish relationships with your clients who are in the ARV 
programme 
 
Participant: What makes good relationships with our patients is that firstly, you need to be friendly, 
your facial expression when greeting the client for the first time,  show the smile, give love , even if 
she has sores touch her, hug her if there is a need because they feel its end of the world and they 
look at your facial expression as you talk to them to watch your reaction , there are those with Ca 
cervix, offensive PV discharge with a smell, but make sure you don’t show them with your 
expressions and open windows, 
 
I: Hmm 
 
P: that’s why we have a good relationship with them because they usually have their problems 
solved after 3 months and how would you feel when you want to come close to her when they are 
better and the client distances herself because you distanced yourself initially 
 
I: Hmm 
 
P: So that’s why they become so close to us 
 
I: Ok 
 
P: The difficult time is the 1st day when coming to start treatment that’s when you need to establish 
good relationship and make the client close to you, don’t scold them , be at their level even if they 
do wrong things don’t shout at them  
 
I: Ok ..What do you think encourage the clients on the programme to stick to their treatment? 
P: Improvement of condition , as they gain weight, have good appetite even those who had warts, 
as they continue with Rx warts also disappear, so general improvement of condition makes them  
realize the importance of sticking to treatment 
 
I: Besides improvement are there any other measures from your side as staff that help clients to 
stick to Rx 
 
P: Yes, Counselling to tell them what will happen to them if they default treatment and to stress 
importance of adherence 
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I: Ok... What do you thing are the barriers of adherence to treatment 
 
P: Some clients come to the programme because they want pension, once they apply for the grant 
they disappear 
 
I: Hmm  
 
P: Those are the people who give us problems, pension is the main problem 
 
I: Ok 
 
P: Clients come to the clinic for the sake of getting pension , some people come to start treatment, 
comes regularly for 3 months keeping appointments well, then assisted to apply for a grant then 
disappear, so they come for the sake of pension especially those who are unemployed  
 
I: Ok, so until when 
 
P: We phone them using contact details in files and trace them 
 
I: Ok  
 
P: Sometimes we find that some are late or some tell us that they don’t want to be on the 
programme anymore, then [sic] we take those out of the programme 
I: Have you ever had instances where they come back after defaulting 
 
P: They come back  we are expecting one defaulter tomorrow, so we’ll make her start literacy 
classes again Dr said so because she was put on the programme then disappeared after grant 
approval, now grant has been discontinued and she has requested to be put back to the 
programme 
 
I: Hmm 
 
P: Some come back when they are sick again 
 
I: So you think the grant also causes people not to stick to treatment 
 
P: Yes some after approval of grant 
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I: Ok... any other barriers to adherence you can think of 
 
P: Others default treatment because they haven’t disclosed at home to families, to husbands, 
boyfriends especially when staying together 
 
I: Ok  
 
P: Then it becomes difficult to come for treatment, some clients meet at the clinic yet they are 
neighbours, and you find client asking you to see her outside and explain that she’s not at ease 
because her neighbour will see her and will know that she is also positive 
 
I: Hmm... Ok thanks. Are there any questions you like to ask me? 
 
P: The only problem that we have is PMTCT training 
 
I: Ok...that’s the department of health responsibility but as my research site I can assist you with 
training on PMTCT and ARVS 
 
P: Ok thank you, may I request your phone number 
I: Ok fine. Thank you for your participation  
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PERMISSION TO CONDUCT RESEARCH REQUESTED 
 
1 Datchet Place 
New Germany 
3610 
01 February 2007 
 
The District Manager 
eThekwini District 
Cc: Clinical Programmes Manager 
 
Dear Sir / Madam 
 
PERMISSION TO CONDUCT RESEARCH 
 
May I request permission to conduct a research study in the Antiretroviral therapy (ARV) clinics in 
eThekwini district? I’m currently working for the Reproductive Health and HIV Research Unit 
(RHRU) and I’m studying towards a PhD degree with Wits University. My study is entitled “An 
exploration of the Experiences of Clients on Antiretroviral Therapy and their Health Care Providers 
in KwaZulu Natal (KZN)” and will involve interviewing clients on ARVs and staff working in ARV 
clinics 
 
I’m enclosing the copy of the research proposal and the interview guide. I’ll appreciate your 
timeous response as your permission is one of the requirements for ethical approval of my 
proposal. 
 
Thanking you in advance. 
 
Yours faithfully 
 
Euphemia Mbali Mhlongo (Mrs)
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PERMISSION TO CONDUCT RESEARCH 
 
1 Datchet Place 
New Germany 
3610 
27 August 2007 
 
 
The District Manager  
eThekwini District Office 
P/Bag X54318 
Durban 
4000 
 
 
Permission to Conduct Research 
 
With reference to your letter dated February 14, 2007, I hereby attach in addition to the proposal 
and interview schedules the Ethics Clearance certificate from University of Witswatersrand, 
Johannesburg. 
May I kindly get your permission to visit ARV clinics in eThekwini district to get consent from 
patients and staff to conduct research? 
 
Thanking you in advance for considering my request 
 
Yours faithfully 
 
E M Mhlongo (Mrs) 
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BRACKETING DOCUMENT 
 
The Researchers’ Experiences with HIV infected Individuals 
 
1. Introduction 
Before the researcher started with data collection and analysis, she needed to suspend all 
beliefs, assumptions and preconceived ideas about experiences with antiretroviral therapy 
as the phenomenon under investigation. The researcher decided to write down all her 
encounters with clients taking antiretroviral therapy and those with health providers. Setting 
aside the researcher’s preconceived ideas helped her to be constantly aware of what she 
believed and tried to keep it separate from what was shared by participants. The researcher 
decided to share experiences about her involvement with the South African antiretroviral 
programme since its inception, experiences with the clients in the sites initiating them on 
antiretroviral therapy and experiences of working with health care providers in the 
antiretroviral initiating sites. 
 
2.  Experiences with the South African Antiretroviral Rollout 
The researcher’s experience of working with HIV infected individuals started in 2004 when 
the South African Government rolled out the National Antiretroviral treatment guidelines. 
These guidelines served to assist the clinic team in the management of patients on 
antiretroviral drugs as outlined in the Comprehensive Plan for HIV and AIDS Care, 
Management and Treatment. 
The researcher was working for the Reproductive Health and HIV Research Unit in Durban 
as an HIV and AIDS and STIs Project Coordinator. As a Unit we were giving programme 
support to the KwaZulu Natal Provincial Department of Health. My work since 2004 was to 
conduct training on comprehensive management of HIV infected individuals including 
antiretroviral therapy to the Primary health care nurses in clinics and hospitals in KwaZulu 
Natal Province.  The researcher was doing training in the eleven health districts in KwaZulu 
Natal Province. She was also providing technical support to the antiretroviral initiating sites 
in eThekwini Health District. Through provision of technical support, the researcher gained 
experience in working with HIV infected clients on antiretroviral therapy, the management of 
opportunistic infections and learnt to understand work life of the health care providers 
rendering antiretroviral treatment services. 
 
3.  Experiences with Clients 
As a trainer, the researcher used to visit the Antiretroviral clinics in the initiating hospitals 
and look at the flow of clients and the proceedings from the time the client enters the clinic 
until she leaves. Her interaction with patients on antiretroviral therapy was when they got 
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into the doctor’s consulting room during history taking and examination. Patients would 
share their experiences before being enrolled in the antiretroviral therapy programme, how 
sick and helpless they were and they’ll compare that with their current wellbeing. Clients 
used to praise the drugs they were taking for their benefits in improving their lives. Clients 
would also indicate that drugs had side effects but their benefits outweighed the risks. 
 
4.  Experiences with Providers 
The researcher established a relationship with clinicians rendering antiretroviral services in 
the initiating sites. For each and every client entering the consulting room, the doctor would 
take me through his or her records from the time the client was registered on the 
programme. The researcher had an opportunity of learning all the details pertaining to the 
number of visits made to the health facility, investigations done, number of flu attacks if any 
and management thereof, drug side effects experienced and management thereof and drug 
switches done if any. During this period the researcher also learnt about the practical 
details of drug regimens, the indications for changing the regimen and when to decide to 
stop antiretroviral therapy. 
 
5.  Personal, Family and Cultural Beliefs about HIV and AIDS 
As a person the researcher believes that HIV infected individuals are human beings who 
deserve to be treated with respect and dignity like all the citizens of the country. The 
researcher as a member of the family and the community which is predominantly Zulu 
speaking is exposed to myths and misconceptions regarding HIV and AIDS. She tries in her 
everyday life to assist friends, relatives and the community at large to understand facts 
about HIV and AIDS in order to overcome the myths. As a Zulu woman, the researcher 
initially had difficulties of raising awareness messages about the subject to communities 
because it is culturally sensitive to talk about sex related issues and negotiating safer sex 
practices in our culture. Values clarification workshops contributed a lot in assisting the 
researcher to separate personal and professional values. Trainings and courses attended 
on HIV and AIDS have also assisted the researcher to deal with her own biases, fears and 
concerns regarding HIV and AIDS.  
 
6.  Conclusion 
Reflecting on these experiences helped the researcher to exclude biases and to adopt a 
non-judgemental attitude throughout the period of data collection and analysis. It also 
assisted her to work with PLWHAs without any discrimination and stigmatization.  It also 
assisted the researcher to remain neutral and made efforts not to influence data by asking 
leading questions to participants. 
 
